Oncology Books

1739 products


  • Tumour Hypoxia: Molecular Mechanisms and Clinical

    Peter Lang AG Tumour Hypoxia: Molecular Mechanisms and Clinical

    1 in stock

    Book SynopsisInsufficient supply of oxygen, i.e. hypoxia, typically occurs in a broad range of solid tumours due to aberrant vasculature. It is a key component of tumour microenvironment that affects many biological processes at molecular, cellular and tissue levels. Adaptive responses to oxygen deficiency shape signal transduction, cell metabolism, proliferation, differentiation, survival, angiogenesis, immunosurveillance etc. and thereby contribute to tumour invasion and metastasis. Presence of tumour hypoxia is significantly associated with poor prognosis and therapy resistance. Therefore, it represents a clinically relevant phenomenon that can be exploited for improvement of existing diagnostic and treatment procedures as well as for development of new targeted strategies. This book summarizes the current state of knowledge on hypoxia-regulated pathways and their biological consequences and describes promising approaches to clinical application of this knowledge. It is the first concise and complex guide to understanding principal basic and medical aspects of tumour hypoxia.Table of ContentsContents: Norma Masson/Peter J. Ratcliffe: Oxygen sensing by HIF hydroxylases – Thomas M.F. Connor/Patrick H. Maxwell: VHL inactivation – Carine Michiels: Oncogenic activation of HIF pathway – Katarzyna J. Nytko/Daniel P. Stiehl/Roland H. Wenger: PHD oxygen sensor function and antioxidants – Agnieszka Loboda/Halina Was/Urszula Florczyk/Alicja Jozkowicz/Jozef Dulak: Hypoxia-driven angiogenesis and other modes of blood vessel formation in tumours – Erik Olai Pettersen: Cell cycle alterations by hypoxic microenvironment – Eoin P. Cummins/Susan F. Fitzpatrick/Cormac T. Taylor: The role of NF-κB in hypoxia-induced gene expression – Roman Hrstka/Petr Müller/Philip J. Coates/Borivoj Vojtesek: Hypoxia and p53 – Thomas Kietzmann: Hypoxia: a powerful signal to induce metabolic changes – Eliska Svastova/Silvia Pastorekova: Hypoxia, regulation of pH and cell migration/invasion – Agnes Görlach: Reactive oxygen species and hypoxia signaling – Olga Krizanova: Calcium transport in hypoxia – Sandra Winning/Joachim Fandrey: HIF and inflammation – Martina Takacova/Tereza Goliasova/Juraj Kopacek: Hypoxia and oncogenic viruses – Sarah Peeters/Philippe Lambin/Ludwig Dubois: Noninvasive hypoxia imaging – Bart Reymen/Philippe Lambin: Hypoxia, hypoxia response and conventional anti-cancer therapy – Kaye J. Williams/Stephanie R. McKeown: Targeting hypoxic cells with bioreductive prodrugs – Annamaria Rapisarda/Nicole Fer/Giovanni Melillo: Targeting the hypoxic tumour microenvironment: a unique role for HIF-1 inhibitors – Claudiu T. Supuran: New drugs interfering with pH regulation in hypoxic tumours.

    1 in stock

    £74.61

  • A Guide to Breast Cancer Research

    Springer A Guide to Breast Cancer Research

    1 in stock

    Book SynopsisPart I: Development and cancer: basic concepts.- Chapter 1: Introductory chapter by Sorlie and Clarke.- Chapter 2: Embryonic mammary gland morphogenesis.- Chapter 3: Breast morphogenesis: from normal development to cancer.- Chapter 4: Single-Cell Analysis in the Mouse and Human Mammary Gland.- Part II: Development and cancer: model systems and approaches.- Chapter 5: Recording lineage history with cellular barcodes in the mammary epithelium and in breast cancer.- Chapter 6: Models for studying ductal carcinoma in situ progression.- Chapter 7: Patient-derived xenografts of breast cancer.- Chapter 8: Rat Models of Breast Cancer.- Part III: Development and cancer: cells of origin and heterogeneity.- Chapter 9: Cells of origin of breast cancer and intertumoral heterogeneity.- Chapter 10: Mechanisms of regulation of cell fate in breast development and cancer.- Chapter 11: Classification of breast cancer through the perspective of cell identity models.- Part IV:  Cellular and molecular basis.- Chapter 12: The Microenvironment in DCIS and its Role in Disease Progression.- Chapter 13: Molecular basis of breast tumor heterogeneity.- Chapter 14: E-cadherin-mediated cell-cell adhesion and invasive lobular breast cancer.- Part V: Signalling pathways.- Chapter 15: Hormone signaling in breast development and cancer.- Chapter 16: RANK/RANKL signaling pathway in breast development and cancer.- Chapter 17: Metabolic Reprogramming and Adaption in Breast Cancer Progression and Metastasis.- Part VI: Metastasis and immunity.- Chapter 18: Microenvironmental regulation of dormancy in breast cancer metastasis: An ally that changes allegiances.- Chapter 19: The Roles of Myeloid Cells in Breast Cancer Progression.- Chapter 20: Immune microenvironment in breast cancer metastasis.- Part VII:  Subtypes, treatment and resistance.- Chapter 21: Clinical Implications of Breast Cancer Intrinsic Subtypes.- Chapter 22: Targeting Estrogen Receptor signalling in breast cancer therapy.- Chapter 23: CDK4/6 inhibitor resistance in ER+ breast cancer.- Chapter 24: HER2-positive breast cancer treatment and resistance.

    1 in stock

    £141.80

  • Elsevier Health Sciences Gunderson and Teppers Clinical Radiation Oncology

    a huge range and FREE tracked UK delivery on ALL orders.

    £217.79

  • AJCC Cancer Staging Manual

    Springer International Publishing AG AJCC Cancer Staging Manual

    1 in stock

    Book SynopsisPlease visit www.cancerstaging.org for information about content updates and staging forms.The AJCC Cancer Staging Manual is used by physicians and health care professionals throughout the world to facilitate the uniform description and reporting of neoplastic diseases. Proper classification and staging of cancer is essential for the physician to assign proper treatment, evaluate results of management and clinical trials, and to serve as the standard for local, regional and international reporting on cancer incidence and outcome.Significantly expanded and developed by international disease site expert panels, the Eighth Edition AJCC Cancer Staging Manual brings together all the currently available knowledge on staging of cancer at various anatomic sites. In this edition, evidence-based TNM staging is supplemented, as appropriate, by selected molecular markers and newly acquired insights into the molecular underpinnings of cancer. This edition features 12 entirely new staging systems, a wide range of changed or new staging definitions, and a refined emphasis on a personalized-medicine approach. To enhance the print and electronic usability of the cancer staging forms, they are now available exclusively for access and downloading at www.cancerstaging.org.The Eighth Edition AJCC Cancer Staging Manual remains the gold standard reference for oncologists, surgeons, pathologists, radiologists, cancer registrars and medical professionals world-wide to ensure that all those caring for cancer patients are fully versed in the language of cancer staging.Trade Review“This is the most recent update of a manual for the staging of adult cancers from the American Joint Committee on Cancer. … This is a valuable reference for students, physicians, scientists, and cancer registrars. With clear descriptions and definitions of terminology, it can be used by experienced practitioners as well as those new to cancer staging. … Overall, this edition is a welcome update, incorporating new advances in cancer knowledge to more accurately reflect modern cancer care.” (Emily L. Albright, Doody's Book Reviews, February, 2017)Table of ContentsPart I General Information on Cancer Staging and End-Results Reporting.- 1. Principles of Cancer Staging.- . Organization of the AJCC Cancer Staging Manual.- 3. Cancer Survival Analysis.- 4. Risk Models for Individualized Prognosis in the Practice of Precision Oncology.- Part II Head and Neck.- 5. Staging Head and Neck Cancers.- 6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck.- 7. Lip and Oral Cavity.- 8. Major Salivary Glands.- 9. Nasopharynx.- 10. HPV-Mediated (p16+) Oropharyngeal Cancer.- 11. Oropharynx (p16−) and Hypopharynx.- 12. Nasal Cavity and Paranasal Sinuses.- 13. Larynx.- 14. Mucosal Melanoma of the Head and Neck.- 15. Cutaneous Squamous Cell Carcinoma of the Head and Neck.- Part III Upper Gastrointestinal Tract.- 16. Esophagus and Esophagogastric Junction.- 17. Stomach.- 18. Small Intestine.- Part IV Lower Gastrointestinal Tract.- 19. Appendix – Carcinoma.- 20. Colon and Rectum.- 21. Anus.- Part V Hepatobiliary System.- 22. Liver.- 23. Intrahepatic Bile Ducts.- 24. Gallbladder.- 25. Perihilar Bile Ducts.- 26. Distal Bile Duct.- 27. Ampulla of Vater.- 28. Pancreas – Exocrine.- Part VI Neuroendocrine Tumors.- 29. Neuroendocrine Tumors of the Stomach.- 30. Neuroendocrine Tumors of the Duodenum and Ampulla of Vater.- 31. Neuroendocrine Tumors of the Jejunum and Ileum.- 32. Neuroendocrine Tumors of the Appendix.- 33. Neuroendocrine Tumors of the Colon and Rectum.- 34. Neuroendocrine Tumors of the Pancreas.- Part VII Thorax.- 35. Thymus.- 36. Lung.- 37. Malignant Pleural Mesothelioma.- Part VIII.- Bone.- 38. Bone (appendicular skeleton, spine, and pelvis).- Part IX Soft Tissue Sarcoma.- 39. Introduction.- 40. Soft Tissue Sarcoma of the Head and Neck.- 41. Soft Tissue Sarcoma of the Trunk and Extremities.- 42. Soft Tissue Sarcoma of the Abdomen and Thoracic Visceral Organs.- 43. Gastrointestinal Stromal Tumor.- 44. Soft Tissue Sarcoma of the Retroperitoneum.- 45. Soft Tissue Sarcoma – Unusual Histologies and Sites.- Part X Skin.- 46. Merkel Cell Carcinoma.- 47. Melanoma of the Skin.- Part XI Breast.- 48. Breast.- Part XII Female Reproductive Organs.- 49. Introduction.- 50. Vulva.- 51. Vagina.- 52. Cervix Uteri.- 53. Corpus Uteri – Carcinoma and Carcinosarcoma.- 54. Corpus Uteri – Sarcoma.- 55. Ovary, Fallopian Tube, and Primary Peritoneal Carcinoma.- 56. Gestational Trophoblastic Neoplasms.- Part XIII Male Genital Organs.- 57. Penis.- 58. Prostate.- 59. Testis.- Part XIV Urinary Tract.- 60. Kidney.- 61. Renal Pelvis and Ureter.- 62. Urinary Bladder.- 63. Urethra.- Part XV Ophthalmic Sites.- 64. Eyelid Carcinoma.- 65. Conjunctival Carcinoma.- 66. Conjunctival Melanoma.- 67. Uveal Melanoma.- 68. Retinoblastoma.- 69. Lacrimal Gland Carcinoma.- 70. Orbital Sarcoma.- 71. Ocular Adnexal Lymphoma.- Part XVI Central Nervous System.- 72. Brain and Spinal Cord.- Part XVII Endocrine System.- 73. Thyroid – Differentiated and Anaplastic Carcinoma.- 74. Thyroid – Medullary Carcinoma.- 75. Parathyroid.- 76. Adrenal Cortical Carcinoma.- 77. Adrenal – Neuroendocrine Tumors.- Part XVIII Hematologic Malignancies.- 78. Introduction.- 79. Hodgkin and Non-Hodgkin Lymphomas.- 80. Pediatric Hodgkin and Non-Hodgkin Lymphomas.- 81. Primary Cutaneous Lymphomas.- 82. Multiple Myeloma and Plasma Cell Disorders.- 83. Leukemia.- Part XIX Additional Contributors.- Index.

    1 in stock

    £80.99

  • Johns Hopkins University Press Understanding Cancer A Patients Guide to

    1 in stock

    Book SynopsisCompassionate, accessible, and informative, Understanding Cancer will increase the reader's knowledge of medical concepts and terms so the person with cancer, the family, and the health care team can work together efficiently-and effectively.Trade ReviewCancer patients who want to be fully informed participants in their own health care will find this a valuable handbook. Publishers Weekly Well written and informative. -- Susan Walker International Journal of Radiation Oncology Biology Physics 2007 This well written, up-to-date book is concise and easy to read and understand. Written in everyday language without being overly simplistic, the book provides clear explanations, examples, and practical advice that can serve as a framework for treatment decisions... 3 stars Doody's Review Service 2007Table of ContentsForeword by Edward C. Halperin, M.D.Foreword to the First Edition by Ellen L. StovallPrefaceIntroduction1. Diagnosis and Treatment: What You Can Expect2. Cancer: Where Does It Come From?3. Diagnostic Tests and Staging Studies: Gathering Information4. Making Decisions about Treatment: How Success Is Measured5. Weighing the Long-Term Risks and Benefits of Treatment6. Conventional Treatments: An Overview7. Molecular-Target Therapy8. Clincial Research Trials: What They're All About9. Clinical Case Studies: Four Patient StoriesAfterwordAppendixesA. Cancer Molecular BiologyB. Analyzing Cost-EffectivenessC. Performance Status Scoring SystemsD. Patient's ChecklistBibligraphyIndex

    1 in stock

    £36.45

  • Dying to Be Me

    Hay House Inc Dying to Be Me

    5 in stock

    Book SynopsisIn this truly inspirational memoir, Anita Moorjani relates how, after fighting cancer for almost four years, her body began shutting down—overwhelmed by the malignant cells spreading throughout her system. As her organs failed, she entered into an extraordinary near-death experience where she realized her inherent worth . . . and the actual cause of her disease. Upon regaining consciousness, Anita found that her condition had improved so rapidly that she was released from the hospital within weeks—without a trace of cancer in her body! Within these pages, Anita recounts stories of her childhood in Hong Kong, her challenge to establish her career and find true love, as well as how she eventually ended up in that hospital bed where she defied all medical knowledge. As part of a traditional Hindu family residing in a largely Chinese and British society, Anita had been pushed and pulled by cultural and religious customs since she was a little girl. After years of struggTrade Review"I have been deeply and profoundly touched by the contents of this book, and even more so by my personal relationship with Anita Moorjani, who came into my life through a series of Divinely orchestrated coincidences." - Dr. Wayne W. Dyer"Describing her ensuing near-death experience as a realm of clarity and expansiveness, 'a state of being,' Moorjani made the choice to return, and her rapid and remarkable recovery defies all medical understanding. Her psychospiritual healing, which continues to this day, was self-realization: of her own magnificence, of oneness with universal energy and with a universe comprising. This candid memoir is a cathartic testimony to the magnificence and healing capacity of every human being." - Publishers Weekly"This book is very thought provoking. Can we take the learnings, and make the changes, from someone else's Near Death Experience? Can I create for myself the same level of faith and knowing just by reading this book? Honestly, I don't think I can. But what I can do is open my mind that little bit more, take this book as another brick in building that wall of strength, and take her learnings with me on my own journey. I recommend that you do that same." - Rachel Bell"I had the pleasure of reading Anita's book after hearing her speak in Sydney, Australia at the end of January. Her NDE experience is profound. The wisdom she shares is life changing." - Cheryl Richardson"This book reminded me how important it is to live life from a place of passion rather than from a place of fear. No matter what challenge life gives us, it's really important to look for the gift in it. This book is truly amazing." - Vibrant Living with Celine

    5 in stock

    £15.29

  • Fasting Cancer

    Penguin Publishing Group Fasting Cancer

    20 in stock

    Book SynopsisA groundbreaking guide to how fasting and nutritechnology are revolutionizing the prevention and treatment of cancer, from the bestselling author of The Longevity DietDespite all our scientific advances, which have allowed us to prevent and treat so many deadly diseases, almost one in two people will develop cancer in the U.S. In Fasting Cancer, Dr. Valter Longo, one of the leading scientists in the field of nutrition and cancer, reveals the results of decades of research on the fasting and nutrition technology−based studies to defeat cancer in the body, making only tumor cells much more vulnerable to therapy while protecting the healthy cells.Fasting Cancer creates a new path in which the patient is an active codriver of the therapy by turning on the body’s ability to fight cancer. Dr. Longo’s studies show that the fasting-mimicking diet is beginning to make cancer therapies potentially more effective and less toxic to pati

    20 in stock

    £24.00

  • Oxford University Press Inc Managing Cancer and Living Meaningfully

    Out of stock

    Book SynopsisManaging Cancer and Living Meaningfully provides valuable insight into the experience of patients and families living with advanced cancer and describes a novel psychotherapeutic approach to help them live meaningfully, while also facing the threat of mortality. Managing Cancer and Living Meaningfully, also known by the acronym CALM, is a brief supportive-expressive intervention that can be delivered by a wide range of trained healthcare providers as part of cancer care or early palliative care. The authors provide an overview of the clinical experience and research that led to the development of CALM, a clear description of the intervention, and a manualized guide to aid in its delivery. Situated in the context of early palliative care, this text is destined to be become essential reading for healthcare professionals engaged in providing psychological support to patients and their families who face the practical and profound problems of advanced disease.Table of ContentsIntroduction Part I: CALM Foundations Chapter 1: The Meaning of Mortality in Modern Life Chapter 2: The Management of Terror Chapter 3: One Thousand Lives: The Work that Influenced CALM Chapter 4: Attachment Security Chapter 5: Mentalization and Mortality Chapter 6: Treatment Decisions and the Therapeutic Process Chapter 7: CALM and the Desire for Death Chapter 8: The Pearl in the Oyster: Posttraumatic Growth Chapter 9: The Context of CALM Chapter 10: Measuring Process and Outcome in CALM Chapter 11: The Experience of CALM Training Chapter 12: From Our Clinic, Across the Globe: CALM Training, Research, and Advocacy Part II: The CALM Treatment Manual Chapter 13: Rationale, Foundations, and Goals of CALM Chapter 14: The Structure and Process of CALM Chapter 15: The CALM Domains Chapter 16: Utilizing Measures in Clinical Practice and Supervision Chapter 17: CALM Therapy Cases Epilogue Appendix A Appendix B Appendix C Appendix D Appendix E Appendix F Appendix G Appendix H Appendix I

    Out of stock

    £999.99

  • Diary of a Detour

    Duke University Press Diary of a Detour

    Book SynopsisDiary of a Detour is film scholar and author Lesley Stern''s memoir of living with chronic lymphocytic leukemia. She chronicles the fears and daily experience of coming to grips with an incurable form of cancer by describing the dramas and delving into the science. Stern also nudges cancer off center stage by turning to alternative obsessions and pleasures. In seductive writing she describes her life in the garden and kitchen, the hospital and the library, and her travels—down the street to her meditation center, across the border to Mexico, and across the world to Australia. Her immediate world is inhabited with books, movies, politics, and medical reports that provoke essayistic reflections. As her environment is shared with friends, chickens, a cat called Elvis, mountain goats, whales, lions, and microbes the book opens onto a larger than human world. Intimate and meditative, engrossing and singular, Diary of a Detour offers new ideas about what it might mean to Trade Review“Diary of a Detour is such a great book, excessive like Lesley Stern's own intense appetite for life that includes her wide knowledge about the intricacies of disease. It's the most pleasurable cancer book imaginable. I was riveted, the specificity of the writing is a drug. Stern has written a wonderful, stirring, magnificent book. Oh, World, you are the love object of this hardworking, self-deprecating extravagant genius.” -- Eileen Myles, author of * Evolution *“Diary of a Detour is wonderful on so many levels. Besides being an extraordinary writer, Lesley Stern is emotionally and intellectually sophisticated in such subtle and deep ways. She outlines the stakes of learning to live and feel in the grip of inescapable finitude and mortality, together with others of many kinds and species, but also alone, as irreducibly this vulnerable person and no other. I love this book.” -- Donna J. Haraway, author of * Staying with the Trouble: Making Kin in the Chthulucene *"What emerges most powerfully is Stern’s determination to live—not just to stay alive but, as Tennyson writes in 'Ulysses,' 'To strive, to seek, to find, and not to yield.' . . . A mixture of the mundane and the medical, the ordinary and the extraordinary." * Kirkus Reviews *"[Stern's] final book, the magnificent Diary of a Detour (2020) that appeared just before her passing, records how the force of obsession – obsessions with planting and tending, with chickens, with the growing and preparing of food, with the cycles of nature – literally prolonged her life, pulling her through into new and brilliant investigations, and an ever-widening collaboration with activists at all levels of the environmental movement." -- Adrian Martin * ArtsHub *Table of ContentsAcknowledgments ix 1. Chickens Saved My Life 1 2. The Time It Takes (By Way of an Introduction) 3 3. Secret 7 4. A Possum Fate (Averted) 9 5. Events Unfold in the Snow 12 6. Chicken Feet 17 7. Why Chickens or Homage to Gloria 18 8. Boomerang 22 9. A Way of Making Another Egg 25 10. Shivers and Shakes 28 11. The Chicken or the Egg 32 12. Strawberry/Fetish 34 13. Life after Life 40 14. The Poetry of Pigs 44 15. Some Musings on Metaphor 45 16. Tricking the Body 51 17. Chicken Joke 53 18. Nice Paint Job 57 19. Frenzied Calm 59 20. Tokhm-e Morgh 73 21. Disability 74 22. Why Me, Lord? 75 23. Five Down, Two to Go 80 24. The Warrior Song of King Gesar 81 25. Euphoria 85 26. A Fern Romance 87 27. Weeding 89 28. Untimely 92 29. Blue/Shimmer 93 30. Missed Connection 109 31. Blown through the Air 111 32. Don't Think about It (For the Moment) 114 33. Spheres of Glass 115 34. Purple Haze 123 35. Cantankerous Rooster 125 36. Dead and Alive: A Tenuous Continuum 128 37. Breakfast Anecdotes 138 38. Landscape 139 39. Tootin Pootin 143 40. Dragon Inn 150 41. All along the Highway 153 42. A Lion's Roar 156 43. The Ecology of Cancer, and What Do Ants Have to Do with It? 158 44. What Does It Matter? 164 45. So Unctuous and So Tender 166 46. Dorland 169 47. Touched by a Whale 174 48. Travel 181 49. The Answer Is Not Coming 182 50. Night Club Bouncers 184 51. All Natural 187 52. Anza Borrego 190 53. Lighten Up 197 54. Glad to Be Here (Plaintive Knowledge) 203 55. Stinging Nettles 205 56. A Talent for Cancer 212 57. Phobia: The Chickens Come Home to Roost 214 58. Walking Meditation 219 59. A Ticket for Tuppence 221 60. Reaching Yirrkala 226 61. Chookless 245 62. Chicken Shit 246 63. Mimetic Pain 250 64. You Are Mostly Not You 254 65. R.I.P. Elvis, the King of the Cats 260 66. Afterlife 263 67. Art Alive 268 68. Bodies in Pieces 271 69. A Prospect of Consolation 275 70. Fig Future 278 71. Between Fresh and Rotten 280 72. Blood Poetry 294 73. Shimmer and Glimmer 295 74. I Need an Advocate 297 75. Nameless 302 76. Fermentation Dreams 306 77. The Structure That a Life Has 309 78. Like a Cat in a Hat, Sleek and Brave: R.I.P. Ryoko 311 79. The Malvolio Gene 314 80. What Do You Expect? 318 81. Chimera 320 82. The Last Chicken Standing 335 83. Arrivderci 338 Notes 343

    £27.90

  • Understanding Cancer

    Taylor & Francis Inc Understanding Cancer

    5 in stock

    Book SynopsisUnderstanding Cancer is a brand new undergraduate textbook for students without prior training in biology that integrates an introduction to cancer medicine with descriptions of the biological processes that go wrong to cause cancer's onset and progression. It also highlights the human side of cancer with stories of patients and loved ones touched by the disease, dealing with diagnosis, treatment, and the prospect of death as well as the broader societal aspects of cancer and its prevention. Key discoveries that have improved our understanding of cancer are presented in sidebars. In spite of this diversity, the book maintains precision and simplicity in describing what is and is not known about cancer, describing the strengths and limitations of current treatmentsTable of Contents1. Cancer and the Biology of Human Cells. 2. Cancer Detection, Diagnosis, and Prognosis. 3. The Organization of Normal Human Cells. 4. How Normal Cells Reproduce and Differentiate. 5. Factors that Promote the Cancerous Transformation of Cells. 6. Oncogenes and their Role in Cancerous Transformation. 7. Tumor Suppressors and their Roles in Resisting Carcinogenic Transformation. 8. Medical Treatment for Cancer. 9. The Immune System and its Relationship to Cancer. 10. A Perspective on "Cancer Futures". 11. Minimizing Cancer Risk. 12. Living with Cancer.

    5 in stock

    £48.99

  • Cancer Diet for the Newly Diagnosed: An

    £15.19

  • Understanding Prostate Cancer Paper Poster

    Scientific Publishing Limited Understanding Prostate Cancer Paper Poster

    7 in stock

    Book SynopsisThis chart provides an overview of the prostate and prostate cancer. Grades and stages are described, with stages illustrated by a series of images. A section on detection and treatment options completes the chart.

    7 in stock

    £14.59

  • Mums Not Having Chemo Cuttingedge therapies

    Little, Brown Book Group Mums Not Having Chemo Cuttingedge therapies

    5 in stock

    Book SynopsisA thoroughly researched and engagingly written book for all those seeking to understand their cancer diagnosis and looking for ways to take a full and empowering role in their recovery.Trade ReviewThis is the book the world needs to change the face of modern health-care - an absolute must for anyone with cancer and their relatives and friends. Facing a diagnosis of 'The Big C' can be terrifying and for most people their treatment plan and daunting future path is presented to them as a fait accompli. The author's mother Gemma Bond chose a path less trodden and this book beautifully documents the emotional rollercoaster she went on, and the physical challenges she faced. Because Laura has a journalistic mind she has thoroughly researched and really dug out not only the facts and science behind alternative treatments and therapies, but she also provides a very human approach from her experience of supporting her mum. Best of all she clearly lays out how to source these options and gives realistic suggestions. This book is unique and it's also a brilliant resource for the currently 'well'. When it comes to building immunity and cancer prevention, there little to rival it. It's moving, inspirational, informative and wonderfully uplifting all at the same time * Janey Lee Grace, TV and radio presenter and author of Imperfectly Natural Woman and Look Great Naturally Without Ditching the Lipstick *An excellent source of information; highly recommended! * Jonathan V. Wright MD *

    5 in stock

    £14.24

  • Taylor & Francis Ltd Operative Surgery of the Colon Rectum and Anus

    15 in stock

    Book SynopsisThe sixth edition of Operative Surgery of the Colon, Rectum and Anus presents the state of the art in colorectal surgery. Edited by world renowned surgeons and with expert chapters from contributors in North America, Europe, and Australasia, the book is essential reading for the experienced surgeon established in colorectal practice as well as advanced trainees in general surgery. Each procedure is described in authoritative text beautifully complemented by high quality step-by-step color artwork and intraoperative photographs, enabling the reader to approach common and rare colorectal conditions with confidence.The book comprehensively covers surgery of the anus, rectum and colon in 87 chapters, grouped into nine sections for ease of reference (General Principles, Proctology, Stomas, Small Intestine, Colon, Rectum, Perineal Reconstruction, Rectal Prolapse and Surgery for Incontinence). The print edition is further enhanced by an accompanying VitalSource eBook, enablinTrade Review"…the editors have succeeded in their stated aim to produce a definitive contemporary textbook of operative colorectal surgery. I think a copy should be available in any hospital library where colorectal surgery is performed…"—Colorectal DiseaseTable of ContentsGeneral Principles. Preparation for colorectal surgery .Safety and positioning in the operating room. Access to abdominal cavity – open. Access to abdominal cavity – laparoscopic. Access to abdominal cavity – hand-assisted laparoscopic surgery. Single incision laparoscopic-assisted colectomy. Access to the abdominal cavity: natural orifice transluminal endoscopic surgery. Anastomotic technique – suture. Anastomotic technique – stapled. Specimen handling. Proctology. Office/outpatient set up. Proctosigmoidoscopy. Flexible endoscopy. Treatment of uncomplicated haemorrhoids. Excision of perianal thrombosis. Open hemorrhoidectomy. Closed hemorrhoidectomy. Stapled hemorrhoidopexy. Perianal sepsis. Anal fistula. Rectovaginal fistula repair. Anal fissure. Anoplasty. Perianal condyloma and anal intraepithelial neoplasia. Perianal skin and anal cancer Pilonidal disease. Stomas. Ileostomy. Colostomy. Stoma closure. Antegrade continence enema procedure in children. Antegrade continent enema procedure in adults. Small intestine. Small bowel resection. Meckel’s diverticulum. Malrotation. Intestinal stricturoplasty. Adhesiolysis. Colon. Appendicectomy – open. Appendicectomy – laparoscopic. Right colectomy – open. Right hemicolectomy – laparoscopic. Right hemicolectomy – hand-assisted laparoscopic surgery. Left colectomy – open. Left hemicolectomy – laparoscopic. Left hemicolectomy – hand-assisted laparoscopic surgery. Colectomy – complete mesocolic excision. Total colectomy – laparoscopic. Total colectomy – HALS. Hartmann’s procedure. Emergency colectomy. Colonic stenting. Rectum. Anterior resection of the rectum. Anterior resection – laparoscopic . Anterior resection – hand-assisted laparoscopic surgery. Anterior resection – robotic. Coloanal anastomosis with intersphincteric resection and colon J-pouch construction. Proctocolectomy for inflammatory bowel disease – open. Proctocolectomy for irritable bowel disease – laparoscopic. Continent ileostomy (Kock reservoir ileostomy). Restorative proctocolectomy with ileal reservoir .Abdominoperineal excision of the rectum and anus. Operative technique for pelvic exenteration. Pelvic exenteration: radical perineal approaches and sacrectomies. Lateral pelvic lymph node dissection in low rectal cancer. Transanal resection for rectal lesions. Transanal endoscopic microsurgery. Presacral resections – Kraske. Surgery for Hirschsprung’s disease. The APPEAR procedure. Vertical reduction rectoplasty for idiopathic megarectum. Perineal reconstruction. VRAM flap. Martius flap. Local advancement flaps. Rectal prolapse. Delorme operation. Perineal rectosigmoidectomy. Abdominal rectopexy – open. Abdominal rectopexy – laparoscopic. Laparoscopic ventral rectopexy. STARR. The EXPRESS procedure. Surgery for incontinence. Surgical repair of the anal sphincters following injury. Sacral nerve stimulation. Construction of an electrically stimulated gracilis neoanal sphincter. Artificial bowel sphincter.

    15 in stock

    £356.25

  • Hoffbrands Postgraduate Haematology

    £169.16

  • Principles and Practice of Head and Neck Surgery

    Taylor & Francis Ltd Principles and Practice of Head and Neck Surgery

    1 in stock

    Book SynopsisThis second edition of an award winning title has been thoroughly updated by a team of world leading head and neck surgeons, oncologists and allied healthcare professionals. Principles and Practice of Head & Neck Surgery and Oncology, 2nd edition is a comprehensive evidence-based account of the current scientific knowledge about head and neck tumors and their management. This book, with over 570 colour images, will provide a valuable source of knowledge and reference for all established specialists and trainees entrusted with the care of patients with head and neck tumors.Trade Review"This book, with over 570 colour images, will provide a valuable source of knowledge and reference for all established specialists and trainees entrusted with the care of patients with head and neck tumors." - Anticancer Research, November 2009"[An] improved, modern, well referenced and timely updated revision, which certainly will provide an excellent knowledge base for trainees across all related specialties involved in the MTD management of head and neck cancer patients." By Pr. Patrick J. Bradley, University of Nottingham, UK, in Oncology News, Jan/Feb 2010"The editors are to be congratulated on presenting in a most attractive way a range of complex material in this rapidly evolving field…the reviewer would strongly recommend its inclusion as a bench book for the multidisciplinary team"…. By John Lowry, In Annals of the Royal College of Surgeons of England, 2004."An outstanding book, one of the best in this complicated field, should be an addition to every budding head and neck surgeon’s collection. A must have!"…In The Internet Journal of Otorhinolaryngology, 2004."An outstanding contribution to the knowledge of head and neck cancer and I would highly recommend it, and it should be a standard text to any library. It should also be required for reading for Head and Neck Oncology trainees and surgeons"…by J P Jeannon, in ENT news, Jan/Feb 04"The Editors are internationally acknowledged in their field of head and neck oncology and this is reflected in their ability to produce a concise, yet wide ranging, text that is fully up-to-date and well referenced. It is indeed very difficult to find fault with this text and I’ve tried, but failed to do so. A concise, truly collaborative effort of high quality and excellent content"…by Kim Ah-See, in The Journal of Laryngology & Otology, 2004. "This book is a beautifully produced, highly illustrated and informative text, that should be on the shelves of every clinical unit that is involved in the management of patients with head and neck malignancy"… In British Journal of Oral and Maxillofacial Surgery, 2004"Each chapter includes practical clinical advice and treatment algorithms useful for those who do not regularly deal with patients who have cancer of the head and neck. This multidisciplinary approach makes the ‘Principles and Practice of Head and Neck Oncology’ an excellent reference for those who have head and neck oncology patients as part of their medical or surgical practice" … by R S Weber & K B Pytynia in British Journal of Cancer, 2004."As well as serving as a superb reference work for head and neck surgeons and clinical oncologists, Principles and Practice of Head and Neck Oncology will be of value to other participants in the multidisplinary of ENT"…by Andrew Swift, in Journal of the Royal Society of Medicine, November 2003."will provide a valuable source of knowledge and reference for all established specialists and trainees entrusted with the care of patients with head and neck tumors"Anticancer Research 29: 2009Table of ContentsPreface Foreword Section I – Basic Principles of Management 1. Head & Neck Malignancy: An Overview 2. Molecular Biology 3. Imaging of Head & Neck Tumours 4. Radiation Therapy for Head and Neck Cancer 5. Chemotherapy for Squamous Cell Carcinoma of the Head and Neck 6. Anaesthesia for Head and Neck Cancer 7. Nursing Care of Head & Neck Cancer Patients 8. Nutritional support of head and neck cancer patients 9. Dental Management of the Head & Neck Patient 10. Palliation of advanced head and neck cancer Section II – Tumour sites and specific tumours 11. Tumours of the Oral Cavity 12. Tumours of the oropharynx 13. Tumours of the Hypopharynx 14. Tumours of the Larynx 15. Management of the Neck 16. Tumours of the Upper Jaw and Anterior Skull Base 17. Juvenile Agiofibroma 18. Tumours of the Nasopharynx 19. Tumours of the Parapharyngeal Space 20. Salivary Gland Neoplasms 21. Management of Tumours of the Temporal Bone 22. Management of thyroid cancer 23. Tumours of the Parathyroid Glands 24. Sarcomas of the Head and Neck 25. Non-melanoma skin cancer 26. Cutaneous Melanoma of the Head and Neck Section III – Complications, Reconstruction, Rehabilitation & Future Developments 27. Complications in Head and Neck Cancer Surgery 28. Principles of Head and Neck Reconstruction 29. Reconstruction of the oral cavity and oropharynx 30. Reconstruction of the Ear 31. Principles of Nasal Reconstruction 32. Functional voice restoration after total laryngectomy 33. Future Developments in Head and Neck Cancer Therapy

    1 in stock

    £427.50

  • Histological Diagnosis of Nevi and Melanoma

    Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Histological Diagnosis of Nevi and Melanoma

    Out of stock

    Book SynopsisThe interpretation of melanocytic tumors represents probably the most difficult task in the field of dermatopathology. The second edition of this text and atlas depicts a broad range of the most important and most challenging melanocytic lesions. Each individual case is illustrated with at least three high-quality color photographs and is commented on at length, highlighting the diagnostic clues. The goal of the authors is to assist the ordinary pathologist in making a precise workable diagnosis in their daily practice. They achieve this by providing simple criteria that will serve as a sound basis for an unequivocal diagnosis of either a benign or a malignant melanocytic neoplasm. The reader will find Histological Diagnosis of Nevi and Melanoma to be an invaluable guide to correct diagnosis even in difficult or rare cases.Trade ReviewFrom the reviews of the second edition:“The book provides a logical, practical classification of melanocytic lesions, using the terminology most frequently used in dermatopathology laboratories. … This is a necessary book that provides useful information for both clinicians and pathologists. … This is a unique, comprehensive source of information for melanocytic lesion histopathology, and a likely must have for pathologists, dermatopathologists, and dermatologists.” (Susan M. Swetter, Doody’s Book Reviews, April, 2014)Table of ContentsCriteria for the Diagnosis of Benign Melanocytic Nevus.- Melanocytic Hyperplasia.- Melanotic Macules.- “Commonon” Nevus.- Congenital Nevus.- Junctional Anomalies in Congenital and Acquired Nevi in the First Year of Life.- Proliferative Nodules in Congenital Nevi.- Nevus Spilus.- Dermal Melanocytoses.- “Common “Blue Nevus.- “Cellular” Blue Nevus.- SPITZ Nevus.- Reed Nevus.- Deep Penetrating Nevus.- Dysplastic & Clarks’s Nevus.- Combinedin Nevus.- Nevi on Acral Skin.- Nevi on Genital Skin.- Nevi in the Oral Cavity.- Polypoid Nevus of Pregnancy and Milk Line Nevi.- Nevi OF the Conjunctiva.- Melanocytic Nevi Affected by inflammatory Skin Dideases.- Halo Nevus.- Recurrent and Persistent Nevus.- Traumatised Nevi.- Benign Melanocytoma.- Medicolegal Cases.- Criteria for the Diagnosis OF Malignant Melanoma.- Melanoma in situ.- Lentigo Maligna.- Superficial Spreading Pattern of Melanoma.- Nodular Pattern of Melanoma.- Melanoma with Spindle Cell.- Nevoid Melanoma.- Spitzoid Melanoma.- Desmoplastic Melanoma.- Neurotropic Melanoma.- Melanoma with Neural Differentiaton.- Myxoid Melanoma.- Melanoma with Features of Blue Nevus.- Animal Type Melanoma.- Melanoma on Blue Nevus.- Unusual and Bizarre forms of Melanoma.- Melanoma on Nevus.- Melanoma on Palms, Soles and Subungual Bed.- Melanoma on Genital Skin.- Melanoma on Oral Cavity.- Melanoma on Conjunctiva.- Recurrent and Persistent Melanoma.- Regressing and Regressed Melanoma.- Cutaneous Metastatic Melanoma.- Malignant Melanocytoma.- Medicolegal Cases.- Molecular Biology in the Diagnosis of Nevi and Melanoma.- Histological Prognostic Factors.

    Out of stock

    £999.99

  • CardioOncology Practice Manual A Companion to

    Elsevier - Health Sciences Division CardioOncology Practice Manual A Companion to

    Book SynopsisTrade Review"Overall, the book provides a succinct blueprint for the field of cardio-oncology. It informs its readers of the ideology necessary to provide quality clinical care in this specific area of medicine and shapes the direction that the field of cardio-oncology will likely take as its importance continues to increase over the coming years." ©Doody's Review Service, 2022, Joseph T Hale, MD MPH Candidate (East Tennessee State University Quillen College of Medicine) Doody's Score: 4 Stars!Table of Contents1. The Cardio-Oncology Clinic Part I. Cardiovascular Disease Management Before Cancer Treatment Section A. The A-to-Z Before Therapy 2. Key Points of Cardio-Oncology Evaluation Before Cancer Therapy 3. Chemotherapeutic Risks Before Cancer Therapy 4. Radiation Therapy Risks Before Cancer Therapy 5. Bone Marrow Transplantation Risks Before Cancer Therapy 6. Surgical Risks Before Cancer Therapy Section B. Cardiovascular Disease Prevention in Cancer Patients 7. Cardiomyopathy/Heart Failure Prevention Before Cancer Therapy 8. Vascular Disease Prevention Before Cancer Therapy 9. Thromboembolic Disease Prevention Before Cancer Therapy 10. Arrhythmia Prevention and Device Management Before Cancer Therapy 11. Hypertension and Renal Disease Prevention Before Cancer Therapy 12. Pulmonary Disease Prevention Before Cancer Therapy 13. Cardiopulmonary Exercise for Prevention Before Cancer Therapy Part II. Cardiovascular Disease Management During Cancer Treatment Section C. The A-to-Z Through Therapy 14. Key Points of Cardio-Oncology Evaluation During Cancer Therapy 15. Cardiomyopathy/Heart Failure Myocarditis, and Takotsubo's During Cancer Therapy 16. Structural Heart Disease 17. Vascular Disease 18. Thromboembolic Disease 19. Arrhythmia, QTc Prolongation, and Device Management 20. Hypertension and Renal Disease 21. Pulmonary Disease 22. Cardiovascular Imaging Part III. Cardiovascular Disease Management After Cancer Treatment Section D. The A-to-Z After Therapy 23. Key Points of Cardio-Oncology Evaluation After Cancer Therapy 24. Cancer Survivorship and Co-Morbidity Disease Risk 25. Long-Term Complications of Chemotherapy 26. Long-Term Complications of Radiation Therapy Section E. Cardiovascular Disease in Cancer Survivors 27. Cardiomyopathy/Heart Failure Prevention and Management 28. Structureal Heart Disease Prevention and Management 29. Vascular Disease Prevention and Management 30. Thromboembolic Disease Prevention and Manageent 31. Arrhythmia Prevention and Management 32. Hypertension and Renal Failure Prevention and Management 33. Pulmonary Disease Prevention and Management 34. Cardiopulmonary Rehabilitation Section F. Cardiovascular Disease Management in Specific Malignant Diseases 35. Breast Cancer 36. Uterine, Ovary, and Cervical Cancer 37. Prostate and Testicular Cancer 38. Renal and Urinary Bladder Cancer 39. Lung Cancer 40. Colorectal Cancer 41. Esophageal and Gastric Cancer 42. Hepatobiliary Carcinomas 43. Pancreatic Cancer 44. Melanoma 45. Head-and-Neck Cancers 46. Thyroid cancer 47. Glioblastoma 48. Bone and Soft Tissue Sarcomas 49. Leukemias 50. Lymphomas 51. Multiple Myeloma and Cardiac Amyloidosis 52. Carcinoid 53. Cardiac Masses Part IV. Cancer Drugs 54. Cancer Therapeutic Drug Guide

    £94.49

  • Edaf Antillas Estrategia Metabolica Contra El Cancer

    1 in stock

    Book Synopsis

    1 in stock

    £22.97

  • The Cancer Diet Cookbook: Comforting Recipes for

    Rockridge Press The Cancer Diet Cookbook: Comforting Recipes for

    7 in stock

    Book Synopsis

    7 in stock

    £16.19

  • 15 in stock

    £23.99

  • Prostate Cancer: A comprehensive guide for

    TFM Publishing Ltd Prostate Cancer: A comprehensive guide for

    10 in stock

    Book SynopsisThis book provides details of all the currently available information concerning the causes, prevention and treatment of prostate cancer, and aims to explain all aspects of the disease in terms that can be easily understood. It deals with the roles of complementary medicine and diet and other aspects for which there is growing evidence, but which many clinicians are reluctant to discuss with their patients.

    10 in stock

    £9.99

  • Tumors of the Pancreas

    American Registry of Pathology Tumors of the Pancreas

    Book SynopsisFree digital access available with every print purchase. See inside the book for more details.While classification of pancreatic neoplasms has not evolved significantly since 2007, data related to the molecular underpinnings that characterize each type of neoplasm have grown exponentially in the past 15 years. The current multimodal study of pancreatic neoplasms has allowed a better understanding of tumor biology, more closely linking the mor¬phologic findings with clinical outcomes and targeted treatment. The prognosis of conventional pancreatic ductal adenocarcinoma remains very poor, but some promise is on the horizon based on novel treatment approaches and the increase in earlier diagnosis. Furthermore, intensive study of other pancreatic neoplasms has led to a clearer recognition that each type has distinctive biology and behavior that is often not so highly aggressive. This sense of optimism may help drive a resurgence of interest in pancreatic pathology.

    £186.30

  • NeuroOncology for the Clinical Neurologist

    Elsevier - Health Sciences Division NeuroOncology for the Clinical Neurologist

    15 in stock

    Book SynopsisTrade Review"The book is one of the best bedside references of neuro-oncology that I have come across. Clinical pearls and case-based teaching are some of its unique features." -© Doody's Review Service, 2021, Sridhar S. Yaddanapudi, MD (Thomas Jefferson University) Doody's Score: 100 - 5 Stars!Table of Contents1. Fundamentals of Neuropathology 2. Basics Principles of Neurosurgical Management of Tumor Patients 3. Radiation Oncology for the Neurologist 4. Evidence-Based Approaches to Chemotherapy for Brain Tumors 5. Emerging Non-pharmacologic Therapies for CNS Tumors 6. Evaluation of a Dural-Based Lesion 7. Evaluation of a Supratentorial Parenchymal Lesion 8. Evaluation of an Infratentorial Lesions (pediatric and adult) 9. Evaluation of Spinal Lesions 10. Evaluation of Peripheral Nerve Lesions 11. Approach to the Meningioma Patient 12. Approach to the Low-Grade Glioma Patient 13. Approach to the High-Grade Glioma Patient 14. Approach to a Brain Metastasis Patient 15. Approach to Leptomeningeal Metastasis Patient 16. Approach to the Patient with Neurofibromatosis: including NF1, NF2 and schwannomatosis 17. Approach to the Patient with Tuberous Sclerosis: including pediatrics and adult 18. Approach to Von Hippel Lindau, Cowden and Other Inherited Conditions 19. Central Nervous System Paraneoplastic Neurological Syndromes 20. Peripheral Nervous System Paraneoplastic Neurological Syndromes 21. Cancer-Associated Perineural Invasion 22. Cancer-Associated Plexopathy 23. Cancer Complications in Patients with Hematologic Malignancies 24. Approach to the Patient with Radiation Necrosis 25. Approach to Radiation Induced Neurocognitive Dysfunction (Beamo-Brain) 26. Uncommon Radiation Induced Neurological Syndromes 27. Approach to the Patient with Acute Chemotherapy Associated CNS Neurotoxicity 28. Approach to the Patient with a Chronic, Delayed Leukoencephalopathy 29. Approach to Chemotherapy Induced Peripheral Neuropathy 30. Approach to Neurocognitive Dysfunction Arising after Chemotherapy (Chemo-Brain) 31. Complications Associated with Immune Checkpoint Therapy 32. Complications Associated with CAR T-cell Therapy

    15 in stock

    £92.69

  • Diagnostic Imaging Oncology

    Elsevier - Health Sciences Division Diagnostic Imaging Oncology

    10 in stock

    Book SynopsisTable of ContentsHead & Neck Lip and Oral Cavity Carcinoma Oropharynx (p16-) and Hypopharynx Carcinoma HPV-Mediated (p16+) Oropharyngeal Carcinoma Nasopharynx Carcinoma Larynx Carcinoma Nasal Cavity and Paranasal Sinuses Carcinoma Salivary Gland Carcinoma Differentiated and Anaplastic Thyroid Carcinoma Thorax Lung Carcinoma Malignant Pleural Mesothelioma Thymus Carcinoma Breast Breast Carcinoma Gastrointestinal Sites Soft Tissue Sarcoma of Abdomen and Thoracic Visceral Organs Soft Tissue Sarcoma of Retroperitoneum Esophagus and Esophagogastric Junction Carcinoma Stomach Carcinoma Small Intestine Carcinoma Appendix Carcinoma Neuroendocrine Tumors of the Appendix Colorectal Carcinoma Anus Carcinoma Gastrointestinal Stromal Tumor Neuroendocrine Tumors of Duodenum and Ampulla of Vater Neuroendocrine Tumors of Colon and Rectum Neuroendocrine Tumors of Jejunum and Ileum Neuroendocrine Tumors of Stomach Hepatocellular Carcinoma Gallbladder Carcinoma Intrahepatic Bile Duct Carcinoma Perihilar Bile Duct Carcinoma Distal Bile Duct Carcinoma Ampulla of Vater Carcinoma Neuroendocrine Tumors of Pancreas Exocrine Pancreas Carcinoma Genitourinary Sites Adrenal Cortical Carcinoma Adrenal Neuroendocrine Tumors Renal Cell Carcinoma Renal Pelvis and Ureter Carcinoma Urinary Bladder Carcinoma Urethra Carcinoma Prostate Carcinoma Testis Carcinoma Gynecologic Sites Cervix Uteri Carcinoma Corpus Uteri Carcinoma Ovary, Fallopian Tube, and Primary Peritoneal Carcinoma Vaginal Carcinoma Vulvar Carcinoma Gestational Trophoblastic Neoplasms Musculoskeletal Sites Primary Malignant Bone Tumor Multiple Myeloma Soft Tissue Sarcoma Systemic Malignancies Hodgkin and Non-Hodgkin Lymphomas Melanoma of Skin

    10 in stock

    £251.09

  • Dermoscopy

    Elsevier Health Sciences Dermoscopy

    Book SynopsisTrade Review"This book presents hundreds of dermatoscopic color images of melanoma, nevi, and non-melanoma skin cancers. The objective is to teach readers how to recognize a skin malignancy by training the eye to scan for the major pertinent criteria. This is an essential skill for all dermatologists to master." -Patricia Wong, MD (Private Practice) Doody's Review ServiceTable of ContentsChapter 1 - Introduction: The 3-point checklist: The short, easy way to avoid missing a melanoma using dermoscopy Technique The 3-point checklist Triage of suspicious pigmented skin lesions Chapter 2 - Pattern analysis: Dermoscopic criteria for specific diagnoses Four global dermoscopic patterns for melanocytic nevi Diagnosis of melanoma using five melanoma-specific criteria Diagnosis of facial melanoma using four site-specific melanoma-specific criteria Four patterns for acral melanocytic lesions Six criteria for diagnosing non-melanocytic lesions Chapter 3 - Common clinical scenarios: Side-by-side comparisons of similar-appearing lesions that are benign or malignant Introduction Pediatric scenario Black lesions Inkspot lentigo Blue lesions Reticular lesions Spitzoid lesions Special nevi Multiple Clark (dysplastic) nevi Follow-up of melanocytic lesions Lesions with regression Flat lesions on the face Nodular lesions on the face Acral lesions Pigmented lesions of the nails Mucosal lesions Differential diagnostic value of blood vessels Amelanotic and partially pigmented melanoma Dermoscopy tests Further reading

    £53.99

  • Oxford University Press Inc Cancer Survivors in Later Life

    Out of stock

    Book SynopsisCancer has been called a disease of the elderly, with advancing age as a risk factor for most cancers and half of all malignancies occurring after the age of 65. With the recent advances in medical care, people are living longer after cancer treatments. The number of cancer survivors is projected to reach 19 million by 2024. Cancer Survivors in Later Life blends existing research with the findings from a major National Cancer Institute-funded study focusing on older adult cancer survivors and the challenges they face. The book is organized into eight chapters that reflect some of the key themes in larger psycho-social oncology, medical oncology, gerontology, and family research literatures. These include cancer and aging, cancer survivorship in later life, cancer and the social self, health and quality of life, functioning and disability, psycho-social distress, adaptation, appraisal and coping, and altered life perspectives after cancer.Within each chapter, the theme introduced is discussed in terms of the prominent foundational and recent research published by those working in the field. This is supplemented by findings from over 20 years of Dr. Deimling''s research in collaboration with colleagues at Cancer Survivors Research Program (CSRP) at Case Western Reserve. In addition to the quantitative data presented, each chapter provides narratives that draw on the lived experiences of respondents in these studies in their own words, making Cancer Survivors in Later Life a multifaceted resource. Readers will find it a state-of-the-art reference for studying the key challenges older adult survivors face in terms of their health, living with cancer, and coping with its after-effects.

    Out of stock

    £999.99

  • Hachette Books The Cancer Revolution

    5 in stock

    Book SynopsisWhen it comes to cancer, conventional doctors are trained to treat their patients exclusively with surgery, radiation, and chemotherapy. These methods are grueling on the whole body - and they don''t treat beyond the tumor or the cancer itself. The focus is on the disease, not the whole person - and because of this, the outcomes in conventional medicine can be bleak. But it doesn''t have to be this way. Dr. Leigh Erin Connealy has developed a whole-person approach to treating cancer - and these treatments have helped thousands of patients through her Cancer Center for Healing. In The Cancer Revolution, Dr. Connealy shows you how to get to the root causes of cancer and the practical steps you can take to get back on the path to healing -- from balancing your body''s chemistry with nutritional supplements, following a healthy food plan, detoxifying your body and home, exercising regularly, getting deep restful sleep every night, practicing stress reduction techniques, and

    5 in stock

    £14.24

  • Springer International Publishing AG Promoting Healing and Resilience in People with Cancer: A Nursing Perspective

    Out of stock

    Book SynopsisThis is the first Nursing book on cancer care designed around a conceptual model of whole person care. Key concepts are stress, healing, resilience and health. As a clinical model, nursing goals, desired outcomes, key concepts and proposed psychosocial interventions with patients and family caregivers, advance the practice of clinical nursing toward a more comprehensive understanding of the whole person with cancer and their loved ones. As a model for teaching nursing students about chronic illness, it provides a scientific basis for students to learn how to assess and care for the whole person and his loved one. As a model for clinical research in the field of cancer care, it serves as a predicate for the development, evaluation and interpretation of clinical interventions. The model is a dynamic framework that both informs and is informed by research findings. It is hoped that future research findings will reveal the optimal combination of interventions to provide comprehensive care across clinical contexts. With a patient-centred humanistic focus anchored by the quality of the nurse patient and family caregiver relationships, it is hoped that the nurse's technical, procedural and medical expertise may complement rather than define the nurse's approach to the whole patient and family. The book is structured to facilitate the reader's easy access to needed information. Each chapter examines a key concept of the model, and is organized around an introduction, learning objectives, definitions, and relevant research findings that serve as the scientific predicate for suggested interventions discussed in Part 4, Nursing approaches. Clinical and personal anecdotes, tables and figures illustrate the concepts under discussion. Nurse practitioners, clinic nurse specialists, nursing professors, graduate students, and nurse researchers may find this book a useful reference for conceptualizing whole person care, and for determining relevant interventions that promote healing, resilience and health. But it is also relevant for family doctors and fourth year students learning to care for the whole person with a chronic illness.Table of ContentsDetailed Table of ContentsPART 1Stress, healing and resilience in the whole person with cancer Chapter 1. Introduction My earliest memories about cancer and healing were derived from a true story my father once told me. He was an ENT surgeon working at an academic hospital in the early 1950s when a curious event concerning one of his patients, occurred. A priest had made an appointment to see my father because of a chronic problem with hoarseness that had befuddled previous doctors. My father located a tumour of the larynx. As per the protocol of the newly established hospital tumour board my father presented the diagnostic evidence, and the board members fully concurred with his diagnosis. A cancer diagnosis was dire in those days, so the evening before the surgery, my father dropped by the priest's hospital room with the nurse-in -charge. The priest was praying, but stopped on seeing his surgeon and the nurse. My father who was not particularly religious, but respectful of the priest's devotion to his faith, asked if they could all pray together, which they did in the priest's room. They were three individuals from different faiths praying to their own higher Being, encompassing the priest with their presence, caring and support. The next morning, my father and the medical residents started the operation. But they soon discovered to their amazement that the tumour had disappeared. It was inexplicable. When I have shared this story with nursing students it has been met, unsurprisingly, with the highest degree of skepticism. A couple of students have had the courage to say what I am sure many others were thinking: that it could be explained away by poor diagnostic tools in those days or medical incompetence! Still, it was equally difficult to dismiss, out of hand, the diagnostic capabilities of a group of surgeons working at an eminent university hospital in Montreal, all members of the Tumour Board, who had arrived at the same conclusion. It was a mystery. Years later, doing research for this book I came across a scientific review of the placebo effect in oncology, now recognized as an innate healing effect, triggered by strongly held cognitive expectations for a positive clinical outcome. Based on WHO criteria, the review reported that the cancer tumours were significantly reduced in about 2.4% or 10 out of 375 patients from 10 trials (Chvetzoff & Tannock, 2003). From a scientific perspective, it was an unimpressive result to be normally discounted out of hand. Yet the finding left open the possibility for the medically inexplicable. Although humans throughout history have been known to heal physical and psychic wounds, it is only recently that medical scientists have come to realize that strongly held human beliefs can trigger innate processes of healing via various physiological pathways such as the reward system, down regulating the stress response system, enabling the re emergence of healing processes that also enhance cell -mediated immunity, a critical anti cancer defense (Colloca & Barsky, 2020; Dutcher & Creswell, 2018). Healing and health in the whole person have been much revered core concepts of the Nursing discipline, since Florence Nightingale's Notes on Nursing, which was published over 100 years ago (Skretkowicz, 2010). Nightingale's scientific observations suggested that distressed patients possessed an innate ability to heal or restore wholeness, when certain environmental conditions, such as uninterrupted sleep, a clean, restful or quiet environment, and a caring and thoughtful approach were implemented. These observations led her to hypothesize that the mind influences physical well being; and conversely, physical health has a significant impact on the mind (Skretkowicz, 2010). Both involved reparative processes within the interactive context of the patient's environment. These mind-body connections laid down the first essential ideas about what constituted the whole person (an integrated mind-body) in relation to stress, health and healing within the discipline of Nursing. Since then Nurse scientists have argued that human beings are more than the sum of their parts, in stanch contrast to a healthcare system mostly shaped by a reductionist perspective in which the clinical focus remains the individual's illness and treatment. Their thinking was also influenced by von Bertalanffy's general systems theory (1973)) and Roger's conceptualization of the human being as an 'irreducible whole', fuelled by homeo-dynamic energy interrelating with the environment' (Malinski 2011, p. 446). Von Bertalanffy (1973) argued that systems are distinguished by non- linear interactions among their constituent parts, which was a prescient idea that has since been supported by research findings that highlight the human's non linear process of biological adjustments in response to environmental stressors (B. S. McEwen, 2007). In other words, the whole person both influences and is influenced by the environment. McGill University's School of Nursing under the leadership of Moyra Allen developed the key concepts of the McGill Model of Nursing. In contrast to prevailing thinking in the 1960s, that health and illness were at opposite ends of the same continuum, the McGill Model envisioned health as co- existing with illness (L. Gottlieb & Rowat, 1987). Influenced by the work of Spiegel (1997) and Bronfenbrenner (1981) health was described in terms of multidimensional developmental processes that grow toward greater complexity and self actualization while maintaining coherence over the life span (L Gottlieb & Gottlieb, 2007).. Around the same time, research in the field of environmental stress and psycho- neuro-endocrine and immune sciences provided scientific legitimacy to Nursing's foundational beliefs about the mind-body relationship, healing and resilience (in terms of both biological as well as psychological processes of adaptation in relation to the environment (e.g.B. McEwen, 2008; B. S. McEwen & Stellar, 1993). McEwen and colleagues built upon earlier landmark research on stress by introducing concepts of allostasis (healthy resilience) to exemplify the adaptive changes that occur in response to stress, and allostatic load (maladaptive changes) to reflect the measurable burden caused by chronic stress on the whole person (McEwen, 2007;McEwen & Stellar, 1993). They advanced knowledge of the whole person through their work on the main biological regulator of stress and the dynamic non -linear networks of biological mediators triggering widespread temporary or prolonged changes to neural structures, pathways and functions throughout the whole being. These stress-induced changes suppress neuro-biological processes (eg the parasympathetic nervous system) associated with regeneration, reparation and restoration (healing) of myriad biological functions including cell mediated immunity, which is vital for promoting long- term health particularly in patients with cancer (Lutgendorf & Andersen, 2015; Lutgendorf, Sood, & Antoni, 2010; Wang et al., 2017). Knowledge of these stress- induced neuro-biological impairments negatively affecting healing and resilient processes have added immeasurably to the clinical context within which resilient- and healing- promoting clinical interventions may be developed and evaluated. These scientific advances underscore the clinical need for an integrated formulation of the whole person based on stress, healing, resilience and related concepts that may be delineated by a conceptual model so that nursing interventions may target relevant unique and overlapping endpoints that promote or protect the individual's resilience and health. This is a clinical imperative in caring for patients with cancer and their family caregiver who must confront diverse stressors along the continuum. Finally I conclude with this last thought: Delineating a substantive body of knowledge that can be leveraged on behalf of patients and loved ones also offers the potential for further levelling of the healthcare playing field within which nursing and medicine continue to exchange biological as well as behavioural perspectives of their shared patients, expressed via the complementary prisms of their respective professions, which together can only benefit the patient and family. Part 1 introduces the Stress, Resilience and Healing Model. Chapter 1 presents the whole person's key concepts of central interest, the desired outcomes and proposed interventions known to enhance healing and resilience. Chapter 2 reviews the different forms of environmental stress; some serve to trigger he development and adaptive capabilities of resilience, others, such as chronically stressful experiences alter neural structures and disrupt signalling pathways and molecular processes that ultimately can drive the development of cancer, its progression, and or a cancer recurrence, particularly in the absence of adequate personal and social resources. ReferencesBenson, Herbert, & Stark, Marg. (1997). Timeless healing : the power and biology of belief. New York: Simon & Schuster.Bertalanffy, Ludwig von. (1973). General system theory : foundations, development, applications. New York: G. Braziller.Bronfenbrenner, Urie. (1981). The ecology of human development: Experiments by nature and design. Cambridge, Mass, and London England: Harvard University Press.Chvetzoff, G., & Tannock, I. F. (2003). Placebo effects in oncology. J Natl Cancer Inst, 95(1), 19-29. Colloca, L., & Barsky, A. J. (2020). Placebo and Nocebo Effects. N Engl J Med, 382(6), 554-561. doi: 10.1056/NEJMra1907805Dutcher, J. M., & Creswell, J. D. (2018). The role of brain reward pathways in stress resilience and health. Neurosci Biobehav Rev, 95, 559-567. doi: 10.1016/j.neubiorev.2018.10.014Gottlieb, L, & Gottlieb, B. (2007). The development/health framework within the McGill Model of Nursing: 'Laws of nature' guiding whole person care. Advances in Nursing Science, 30(1), E43-57. Gottlieb, L. , & Rowat, K. (1987). The McGill Model of Nursing: A practice derived model. Advance in Nursing Science, 9(4), 51-61. Lutgendorf, S. K., & Andersen, B. L. (2015). Biobehavioral approaches to cancer progression and survival: Mechanisms and interventions. Am Psychol, 70(2), 186-197. doi: 10.1037/a0035730Lutgendorf, S. K., Sood, A. K., & Antoni, M. H. (2010). Host factors and cancer progression: biobehavioral signaling pathways and interventions. J Clin Oncol, 28(26), 4094-4099. doi: 10.1200/jco.2009.26.9357Malinski , V. M. (2011). Models and theories focused on human existence. Sudbury,MA: Jones & Bartlett Learning McEwen, B. (2008). Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. European Journal of Pharmacology, 583, 174-185. McEwen, B. S. (2007). Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev, 87(3), 873-904. doi: 10.1152/physrev.00041.2006McEwen, B. S., & Stellar, E. (1993). Stress and the individual. Mechanisms leading to disease. Arch Intern Med, 153(18), 2093-2101. Skretkowicz, Victor (2010). Florence Nightingale's Notes on Nursing and Notes on Nursing for the Labouring Classes. New York: Springer Publishing Co.Spiegel, Daniel. (1997). The developing mind T. G. Press (Ed.)Wang, M., Zhao, J., Zhang, L., Wei, F., Lian, Y., Wu, Y., . . . Guo, C. (2017). Role of tumor microenvironment in tumorigenesis. J Cancer, 8(5), 761-773. doi: 10.7150/jca.17648 PART 2ResilienceChapter 4. Introduction Part 2 explores resilience from both biological and psychological perspectives in Chapters 1 and 2, respectively. Although the two are integrated within the human organism the decision to present each resilient process separately is based on how much there is to cover in order to heighten clinical awareness of key biological and psychological clinical targets and processes associated with resilience, in the most straightforward and understandable format. Knowledge of the processes of adaptation can serve as the basis of clinical assessments and interventions aimed at strengthening our patient's healing and resilient capabilities particularly during the vulnerable phases of the disease and treatment. As relevant, connections between biological and behavioural processes will be made throughout both chapters raising clinical implications for care. PART 3Poor resilienceChapter 7. Introduction Part 3 is designed to demonstrate the toxic biological and psychological impairments resulting from chronic stress that lead to poor resilient capabilities. If left unregulated, this mal-adaptation to stress facilitates the development of cancer or another chronic illness depending on the individual's genetic predisposition. Chapter 1, discusses the clinical significance of poor resilience which is the inability of the human organism to adapt biologically or cope behaviourally in the face of chronic stress, with progressively deleterious patho-physiological and psychosocial behavioural consequences(McEwen, 2015)). Poor resilience is associated with widespread damage to brain cell structures, synapses, and other biological pathways and functions which contribute to systemic inflammation. These neurobiological impairments throughout the human organism, caused by chronic stress strains the individual's ability to cope effectively, imposing a metabolic burden. When chronic stress is unregulated, the consequence ultimately is oxidative stress caused by an imbalance of reactive oxygen species (ROS) to anti oxidants, favouring ROS which damage cells and even DNA (McEwen, 2007)). In Chapter 2 we learn how these biological damages mediated by stress-induced epigenetic changes threaten homeostasis, healing processes, and immune defences which are now thought to be the scientific predicate for tumorigenesis, cancer progression and metastases, ultimately threatening the survival of the human organism (Andersen et al., 2008; Lutgendorf, 2012; McEwen, 2015). The purpose of Part 3 is to provide a comprehensive albeit simplified portrait of the whole person whose biology is progressively overloaded by an inchoate systemic inflammatory environment mediated by the quality of the individual's personal resources, supportive relationships, coping skills, lifestyle behaviours as well as other clinical environmental factors that also contribute to allostatic load/overload. Through this description, it is hoped that the clinical interventions to be discussed in Part 4 and Part 5 find their rationale with clear end targets within the larger context of the psycho-social and biological human being. And as you read about the progressive biological impairments due to stress which are further exacerbated by the tumour and its various treatments, it helps to remember that the stress- induced epigenetic changes are still reversible with effective interventions, and can still offer the individual an enhanced quality of life, an overall sense of well being, and for most, at least some relief from emotional distress/ existential suffering. Andersen, B. L., Yang, H. C., Farrar, W. B., Golden-Kreutz, D. M., Emery, C. F., Thornton, L. M., . . . Carson, W. E., 3rd. (2008). Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer, 113(12), 3450-3458. doi: 10.1002/cncr.23969Lutgendorf, S., De Geest, K, Bender, D., Ahmed A., Goodheart M., Dahmoush, L., Zimmerman M, et al (2012). Social influences on clinical outcomes of patients with ovarian cancer. Journal of Clinical Oncology, 30(23), 2885-2890. McEwen, B. S. (2007). Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev, 87(3), 873-904. doi: 10.1152/physrev.00041.2006McEwen, B. S. (2015). Biomarkers for assessing population and individual health and disease related to stress and adaptation. Metabolism, 64(3 Suppl 1), S2-S10. doi: 10.1016/j.metabol.2014.10.029PART 4Fostering healingChapter 10. Introduction Facilitating healing in nursing practice has to do with making an individual feel whole. Healing may be conceptualized in different interrelated ways. In the first half of this book, we learned about the role of healing in biological and psychological resilience. In PART 4 healing is addressed in terms of diverse strategies that may be mobilized by the nurse to foster innate and self- induced processes of healing in order to strengthen or restore the individual's resilient capabilities. Each chapter addresses a specific therapeutic approach and its respective role in influencing processes of healing and resilience. Theoretical and empirical perspectives are covered. We examine ways that nurses may leverage related scientific theory and evidence to offer healing or resilient- strengthening strategies. Therapeutic approaches are derived from both conventional and complementary modes of nursing practice. Chapter 11 discusses the key elements within the quality of the nurse-patient relationship that are conducive to creating a healing environment. Key components include the nurse's competence, effective communication, compassion, and sense of compassion, strengthened by a heightened sense of shared humanity and a shared belief that the patient is known by the nurse and his or her healthcare team (e.g.Durkin, Usher, & Jackson, 2019). Chapter 12 discusses nursing strategies in promoting emotion- regulating cognitive and behavioural coping capabilities of resilience. These strategies include facilitating more positive re appraisals of the cancer- and treatment-related threats, shifting patient goals and expectations toward new cognitive and behavioural coping skills, problem -solving skills for better self management of clinical issues in order to adapt more effectively to health- related stresses in the future (Antoni, 2013; Dunkel-Schetter, Feinstein, Taylor, & Falke, 1992; Jassim, Whitford, Hickey, & Carter, 2015). Personal and social resources or strengths that may be leveraged by the nurse to foster more effective coping capabilities in the face of adversity are also discussed. Chapter 13 has to do with fostering meaning in patients and caregivers who are struggling to find meaning in the face of a cancer diagnosis or a shortened life (e.g.Lee, Cohen, Edgar, Laizner, & Gagnon, 2006; Vehling & Philipp, 2018). Fostering meaning is approached from a theoretical and evidentiary perspective that serves as the predicate for suggesting relevant therapeutic approaches (Folkman, 2007; Park & Folkman, 1997; Vehling & Philipp, 2018). It reviews ways that the individual may come to terms with a threatening event such as the diagnosis of cancer, and or find new meaning in the cancer experience through the guided process of re-ordering and realigning beliefs and assumptions about the world and the self as a function of clinical realities. Chapter 14 has to do with ways to strengthen supportive relationships with close family members, as exemplified by the family caregiver. Research findings strongly suggest that patients heal when they are socially attached to loved ones who provide the support they need (Antoni et al., 2012; Lutgendorf, 2012). Chapter 15 addresses the potential healing effects of positive conscious beliefs or expectations of clinical benefits (Benson & Stark, 1997; Colloca & Barsky, 2020). These convictions may be based on previous experiences within the health care system or from family stories, or the health- related experiences of friends. The nurse may play an important role in supporting these expectations knowing that they trigger the biological reward system which has been shown to down regulate the stress response system and enable healing processes to re emerge. Similarly, the patients ' clinical outcomes may be modulated by the negative beliefs they hold regarding their treatment (e.g.Petrie & Rief, 2019). Aspects of the clinical environments that can further interfere with the goals of treatment by inadvertently suppressing healing effects are also highlighted and suggested strategies to counteract these potential ill effects are examined. Chapter 16 discusses self-induced healing strategies for instance through physical exercise or meditation which can induce the physiological relaxation response, again resulting in the down regulation of the stress response, facilitating the re emergence of critical biological healing or reparative processes (e.g.Bhasin et al., 2013; Carlson, 2016). Finally, Chapter 17 presents the critical role of touch and reiki in inducing therapeutic healing benefits in patients and caregivers (Jakubiak & Feeney, 2017; Post-White et al., 2003). ReferencesAntoni, M. H. (2013). Psychosocial intervention effects on adaptation, disease course and biobehavioral processes in cancer. Brain Behav Immun, 30 Suppl, S88-98. doi: 10.1016/j.bbi.2012.05.009Antoni, M. H., Lutgendorf, S. K., Blomberg, B., Carver, C. S., Lechner, S., Diaz, A., . . . Cole, S. W. (2012). Cognitive-behavioral stress management reverses anxiety-related leukocyte transcriptional dynamics. Biol Psychiatry, 71(4), 366-372. doi: 10.1016/j.biopsych.2011.10.007Benson, Herbert, & Stark, Marg. (1997). Timeless healing : the power and biology of belief. New York: Simon & Schuster.Bhasin, M. K., Dusek, J. A., Chang, B. H., Joseph, M. G., Denninger, J. W., Fricchione, G. L., . . . Libermann, T. A. (2013). Relaxation response induces temporal transcriptome changes in energy metabolism, insulin secretion and inflammatory pathways. PLoS One, 8(5), e62817. doi: 10.1371/journal.pone.0062817Carlson, L. E. (2016). Mindfulness-based interventions for coping with cancer. Ann N Y Acad Sci, 1373(1), 5-12. doi: 10.1111/nyas.13029Colloca, L., & Barsky, A. J. (2020). Placebo and Nocebo Effects. N Engl J Med, 382(6), 554-561. doi: 10.1056/NEJMra1907805Dunkel-Schetter, C., Feinstein, L. G., Taylor, S. E., & Falke, R. L. (1992). Patterns of coping with cancer. Health Psychol, 11(2), 79-87. doi: 10.1037//0278-6133.11.2.79Durkin, J., Usher, K., & Jackson, D. (2019). Embodying compassion: A systematic review of the views of nurses and patients. J Clin Nurs, 28(9-10), 1380-1392. doi: 10.1111/jocn.14722Folkman, S., & Moskowitz, J. . (2007). Positive affect and meaning-focused coping during significant psychological stress. In H. A. W. S. M.Hewstone, J.B.F. de Wit, K. van den Bos, & M.S. Stroebe (Eds.), (Ed.), The scope of social psychology: Theory and applications (pp. 193-208). New York: NY:: Psychology Press.Jakubiak, B. K., & Feeney, B. C. (2017). Affectionate Touch to Promote Relational, Psychological, and Physical Well-Being in Adulthood: A Theoretical Model and Review of the Research. Pers Soc Psychol Rev, 21(3), 228-252. doi: 10.1177/1088868316650307Jassim, G. A., Whitford, D. L., Hickey, A., & Carter, B. (2015). Psychological interventions for women with non-metastatic breast cancer. Cochrane Database Syst Rev, 5, CD008729. doi: 10.1002/14651858.CD008729.pub2Lee, V., Cohen, S. R., Edgar, L., Laizner, A. M., & Gagnon, A. J. (2006). Meaning-making and psychological adjustment to cancer: development of an intervention and pilot results. Oncol Nurs Forum, 33(2), 291-302. doi: 10.1188/06.onf.291-302Lutgendorf, S., De Geest, K, Bender, D., Ahmed A., Goodheart M., Dahmoush, L., Zimmerman M, et al (2012). Social influences on clinical outcomes of patients with ovarian cancer. Journal of Clinical Oncology, 30(23), 2885-2890. Park, Crystal, & Folkman, Susan. (1997). Meaning in the Context of Stress and Coping. Review of General Psychology, 1, 115-144. doi: 10.1037/1089-2680.1.2.115Petrie, K. J., & Rief, W. (2019). Psychobiological Mechanisms of Placebo and Nocebo Effects: Pathways to Improve Treatments and Reduce Side Effects. Annu Rev Psychol, 70, 599-625. doi: 10.1146/annurev-psych-010418-102907Post-White, J., Kinney, M. E., Savik, K., Gau, J. B., Wilcox, C., & Lerner, I. (2003). Therapeutic massage and healing touch improve symptoms in cancer. Integr Cancer Ther, 2(4), 332-344. doi: 10.1177/1534735403259064Vehling, S., & Philipp, R. (2018). Existential distress and meaning-focused interventions in cancer survivorship. Curr Opin Support Palliat Care, 12(1), 46-51. doi: 10.1097/spc.0000000000000324PART 5Clinical approaches Chapter 18. Introduction Part 5 addresses the main health-related concerns of patients and caregivers in respective chapters across the diagnostic (Chapter 19), treatment (Chapter 20), transition to survivorship (Chapter 21) and end- of -life (Chapter 22) phases; and psycho-social interventions predicated on evidence from clinical trials, systematic reviews and or meta analysis, are suggested. Nursing interventions are directed toward reducing emotional distress, promoting healing, strengthening resilient capabilities, and improving healthy lifestyles and the well being of the whole person even when there is no cure. However the first nursing objective must be to reduce emotional distress (Andersen et al., 2007; Riba et al., 2019) Through these clinical objectives, the nurse supports the medical goals of treatment by increasing the likelihood of the patients' ability to complete treatment. These psycho-social nursing objectives may also enhance the patients' and family caregivers' ability to live well with the disease as a chronic illness, thrive in survivorship and face the end of life in acceptance and serenity. These objectives are enabled by the quality of the therapeutic nurse-patient relationship across the continuum. One consistent theme exists throughout the cancer experience: the emotional distress of patients and caregivers (Hagedoorn, Sanderman, Bolks, Tuinstra, & Coyne, 2008; Riba et al., 2019). It may ebb and flow depending on the stage of disease, treatment and clinical results, but it always hovers in some form, posing a potential physical threat to patients' and family caregivers' future health. An estimated 20% to 52% of patients report high levels of distress depending on the stage and type of cancer, and its cancer- and treatment- related symptoms and side effects (Dans et al., 2017; Riba et al., 2019). An estimated 10-60% of caregivers experience similar anxiety, depression, grief, and poor physical health across the continuum, which may exceed that of patients, especially toward the terminal phase (e.g.Ahn, Romo, & Campbell, 2020; Dionne-Odom et al., 2016).). Given the emotional interdependence between patients and caregivers which impact their respective psychological and physical health, it is incumbent upon nurses to address the psychological and physical needs of both at all phases, starting at diagnosis and continuing throughout the disease and transition to survivorship (Ferrell 2018). Patient centred The findings from meta analyses and clinical trials that have assessed the effectiveness of various patient-centered psychosocial and behavioral interventions across the stages of disease, have generally reported positive patient outcomes with respect to quality of life, anxiety, depression and marital relationship (Hu, Liu, & Li, 2019; Kalter et al., 2018; Salsman et al., 2019). Patient- centered therapeutic interventions consisted of one or more of the following: providing relevant information, enhancing supportive relationships (Andersen (Andersen et al., 2007) coping skills training (Cohen et al., 2011)), meaning making (Lee, Cohen, Edgar, Laizner, & Gagnon, 2006)), mindfulness based cancer recovery intervention (Carlson et al., 2016)), mindfulness- based stress reduction (MBSR) interventions (Reich et al., 2017)), different modalities of meditation that often include the relaxation response technique (Bhasin et al., 2013)), and various strategies for symptom management (e.g.Lau et al., 2020)), and self management strategies (McCorkle et al., 2011). Ascertaining the most appropriate intervention(s) depends on the goals of care, the clinical target(s) and preferences of the patient. Patient-caregiver focus When patients are accompanied by the family caregiver, clinical interventions tend to focus on the patient based on a partially misplaced assumption that helping the patient helps the caregiver. Too often, the unique and mounting psychological, physical and informational needs of the caregiver with disease progression are neglected. This is an important clinical issue when both caregiver and patients at clinic visits are seen, and the caregiver's needs are assumed to be the same as the patient's (Dionne-Odom et al., 2015). The few studies reporting caregiver as well as patient improvements may reflect the extent to which the clinical interventions addressed their shared concerns (Northouse et al., 2013). This clinical finding underscores the importance of doing a nursing assessment of the patient and the caregiver. Caregiver focus In the year following a cancer diagnosis, correlational findings have suggested that as patient well being improved, caregiver health declined (Shaffer, Kim, & Carver, 2016). Although caregiver needs clearly increase as the patients' (their loved ones) cancer progresses toward its terminal phase, the finding highlights the unique experiences of family caregivers as well as the bidirectional effects on one another 's health (Kershaw et al (Kershaw et al., 2015). Clinical interventions that do not address caregiver concerns earlier in the disease trajectory will likely undermine the health of both patient and caregiver. Many nurses try to set aside meaningful time for patients and their informal caregivers, particularly at distressing moments. But the clinical reality too often is that patient and caregiver needs for psychosocial nursing interventions face a tremendous professional hurdle in hospital settings in particular where nursing goals are predominantly centred on treatment and physical symptoms related to the cancer or treatment. Neither staff rotations nor daily staff schedules build in qualitative time for patients and caregivers (e.g.Molin, 2018)). Although the psycho social interventions discussed in Part 4 fall within the purview of advanced nursing practice, there appears to be sufficient evidence to suggest that most clinic nurses would benefit from more psycho-social skills training as evidenced in part by the number of controlled studies in which the clinic nurses carrying out, for instance, self management interventions required further skill formation (Dionne-Odom et al., 2015). It is hoped that Part 5 which offers nurses an essential repository of clinical interventions supported by the latest scientific findings and the conceptual model, will help to foster a shift in nursing goals and objectives toward clinical interventions that address the psychosocial needs of the whole individual. Ahn, S., Romo, R. D., & Campbell, C. L. (2020). A systematic review of interventions for family caregivers who care for patients with advanced cancer at home. Patient Educ Couns. doi: 10.1016/j.pec.2020.03.012Andersen, B. L., Farrar, W. B., Golden-Kreutz, D., Emery, C. F., Glaser, R., Crespin, T., & Carson, W. E., 3rd. (2007). Distress reduction from a psychological intervention contributes to improved health for cancer patients. Brain Behav Immun, 21(7), 953-961. doi: 10.1016/j.bbi.2007.03.005Bhasin, M. K., Dusek, J. A., Chang, B. H., Joseph, M. G., Denninger, J. W., Fricchione, G. L., . . . Libermann, T. A. (2013). Relaxation response induces temporal transcriptome changes in energy metabolism, insulin secretion and inflammatory pathways. PLoS One, 8(5), e62817. doi: 10.1371/journal.pone.0062817Carlson, L. E., Tamagawa, R., Stephen, J., Drysdale, E., Zhong, L., & Speca, M. (2016). Randomized-controlled trial of mindfulness-based cancer recovery versus supportive expressive group therapy among distressed breast cancer survivors (MINDSET): long-term follow-up results. Psychooncology, 25(7), 750-759. doi: 10.1002/pon.4150Cohen, L., Parker, P. A., Vence, L., Savary, C., Kentor, D., Pettaway, C., . . . Radvanyi, L. (2011). Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy. Psychosom Med, 73(3), 218-225. doi: 10.1097/PSY.0b013e31820a1c26Dans, M., Smith, T., Back, A., Baker, J. N., Bauman, J. R., Beck, A. C., . . . Scavone, J. L. (2017). NCCN Guidelines Insights: Palliative Care, Version 2.2017. J Natl Compr Canc Netw, 15(8), 989-997. doi: 10.6004/jnccn.2017.0132Dionne-Odom, J. N., Azuero, A., Lyons, K. D., Hull, J. G., Prescott, A. T., Tosteson, T., . . . Bakitas, M. A. (2016). Family Caregiver Depressive Symptom and Grief Outcomes From the ENABLE III Randomized Controlled Trial. J Pain Symptom Manage, 52(3), 378-385. doi: 10.1016/j.jpainsymman.2016.03.014Dionne-Odom, J. N., Azuero, A., Lyons, K. D., Hull, J. G., Tosteson, T., Li, Z., . . . Bakitas, M. A. (2015). Benefits of Early Versus Delayed Palliative Care to Informal Family Caregivers of Patients With Advanced Cancer: Outcomes From the ENABLE III Randomized Controlled Trial. J Clin Oncol, 33(13), 1446-1452. doi: 10.1200/jco.2014.58.7824Hagedoorn, M., Sanderman, R., Bolks, H. N., Tuinstra, J., & Coyne, J. C. (2008). Distress in couples coping with cancer: a meta-analysis and critical review of role and gender effects. Psychol Bull, 134(1), 1-30. doi: 10.1037/0033-2909.134.1.1Hu, Y., Liu, T., & Li, F. (2019). Association between dyadic interventions and outcomes in cancer patients: a meta-analysis. Support Care Cancer, 27(3), 745-761. doi: 10.1007/s00520-018-4556-8Kalter, J., Verdonck-de Leeuw, I. M., Sweegers, M. G., Aaronson, N. K., Jacobsen, P. B., Newton, R. U., . . . Buffart, L. M. (2018). Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: An individual patient data meta-analysis of 22 RCTs. Psychooncology, 27(4), 1150-1161. doi: 10.1002/pon.4648Kershaw, T., Ellis, K. R., Yoon, H., Schafenacker, A., Katapodi, M., & Northouse, L. (2015). The Interdependence of Advanced Cancer Patients' and Their Family Caregivers' Mental Health, Physical Health, and Self-Efficacy over Time. Ann Behav Med, 49(6), 901-911. doi: 10.1007/s12160-015-9743-yLau, B. H. P., Chow, A. Y. M., Ng, T. K., Fung, Y. L., Lam, T. C., So, T. H., . . . Wong, D. F. K. (2020). Comparing the efficacy of integrative body-mind-spirit intervention with cognitive behavioral therapy in patient-caregiver parallel groups for lung cancer patients using a randomized controlled trial. J Psychosoc Oncol, 38(4), 389-405. doi: 10.1080/07347332.2020.1722981Lee, V., Cohen, S. R., Edgar, L., Laizner, A. M., & Gagnon, A. J. (2006). Meaning-making and psychological adjustment to cancer: development of an intervention and pilot results. Oncol Nurs Forum, 33(2), 291-302. doi: 10.1188/06.onf.291-302McCorkle, R., Ercolano, E., Lazenby, M., Schulman-Green, D., Schilling, L. S., Lorig, K., & Wagner, E. H. (2011). Self-management: Enabling and empowering patients living with cancer as a chronic illness. CA Cancer J Clin, 61(1), 50-62. doi: 10.3322/caac.20093Molin, J., Lindgren, B.,Graneheim, U, Ringner, A. . (2018). Time together: a nursing intervention in psychiatric inpatient care-feasibility and effects. Int. J. Ment. Health Nurs., 27(6), 1698-1708. Northouse, L. L., Mood, D. W., Schafenacker, A., Kalemkerian, G., Zalupski, M., LoRusso, P., . . . Kershaw, T. (2013). Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers. Psychooncology, 22(3), 555-563. doi: 10.1002/pon.3036Reich, R. R., Lengacher, C. A., Alinat, C. B., Kip, K. E., Paterson, C., Ramesar, S., . . . Park, J. (2017). Mindfulness-Based Stress Reduction in Post-treatment Breast Cancer Patients: Immediate and Sustained Effects Across Multiple Symptom Clusters. J Pain Symptom Manage, 53(1), 85-95. doi: 10.1016/j.jpainsymman.2016.08.005Riba, M. B., Donovan, K. A., Andersen, B., Braun, I., Breitbart, W. S., Brewer, B. W., . . . Darlow, S. D. (2019). Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 17(10), 1229-1249. doi: 10.6004/jnccn.2019.0048Salsman, J. M., Pustejovsky, J. E., Schueller, S. M., Hernandez, R., Berendsen, M., McLouth, L. E. S., & Moskowitz, J. T. (2019). Psychosocial interventions for cancer survivors: A meta-analysis of effects on positive affect. J Cancer Surviv, 13(6), 943-955. doi: 10.1007/s11764-019-00811-8Shaffer, K. M., Kim, Y., & Carver, C. S. (2016). Physical and mental health trajectories of cancer patients and caregivers across the year post-diagnosis: a dyadic investigation. Psychol Health, 31(6), 655-674. doi: 10.1080/08870446.2015.1131826

    Out of stock

    £999.99

  • Springer International Publishing AG Handbook of Multiple Myeloma

    Out of stock

    Book SynopsisThis handbook is an in-depth and comprehensive guide to the pathophysiology, diagnosis, staging, treatment and management of patients with multiple myeloma. The Handbook was commissioned to address an unmet need for a book of this kind in the myeloma field and to provide busy healthcare professionals with an informative and educational review of the current and emerging treatment recommendations for multiple myeloma. Myeloma is a type of bone marrow cancer arising from plasma cells and is the second most common form of bone marrow cancer, but represents just 1% of all cancers. The causes of myeloma are not fully understood but it is thought to be caused by an interaction of both genetic and environmental factors. This Handbook discusses these issues as well the latest developments in the field and will be an invaluable source of topical information for all healthcare professionals with an interest in multiple myeloma.Table of Contents​Pathophysiology.- Diagnosis and staging.- Treatment of transplant eligible patients.- Treatment of elderly patients.- Treatment of relapsed patients.- Bone disease.

    Out of stock

    £999.99

  • Oxford American Handbook of Oncology Oxford

    3 in stock

    £21.74

  • Vaccines for the Prevention of Cervical Cancer

    Oxford University Press Vaccines for the Prevention of Cervical Cancer

    3 in stock

    Book SynopsisThis practical pocketbook provides an overview of the role of HPV in the pathophysiology of cervical cancer and its current screening and management, the principles of immune control of HPV infection in cervical cancer, and the challenges of implementing HPV vaccines and future developments.Table of Contents1. The UK cervical screening programme ; 2. Management of cervical intraepithelial neoplasia (CIN) ; 3. Role of HPV in cervical carcinogenesis ; 4. HPV and genital cancer: the essential epidemiology ; 5. The role of HPV testing in cervical screening ; 6. Natural immune control of HPV infection ; 7. Prophylactic HPV vaccines: pre-clinical and proof of principle studies ; 8. Prophylactic HPV vaccination: current status ; 9. Introduction of HPV prophylactic vaccination ; 10. HPV vaccination in the developing world ; 11. Screening post vaccination ; 12. Second-generation HPV prophylactic vaccines ; 13. Therapeutic HPV vaccines ; 14. Conclusion

    3 in stock

    £22.87

  • Art Therapy and Cancer Care

    Open University Press Art Therapy and Cancer Care

    2 in stock

    Book SynopsisInspired by the experience of art therapists who have pioneered work with people with cancer and including those who have experienced this devastating illness at first hand, this book acknowledges the outstanding work of the Corinne Burton Trust which has supported the development of art therapy services in hospices and clinics throughout the United Kingdom. Narratives, case studies, new theoretical insights, and the inclusion of writing from Italy, France and the United States of America contribute to the strength and originality of the book. Therapeutic work is placed in its institutional context, demonstrating the importance for the art therapy service of being understood, supported and valued at managerial level â and how the lack of this can impact adversely on patient care. Moreover, many of the contributions have a sociological and anthropological nature, which gives the book a unique and challenging dimension. Art Therapy and Cancer Care is key reading for art therTable of ContentsAcknowledgementsForeward by Sir Michael BurtonList of ContributorsIntroductionOn Death and Dying Betwixt and Between: Crossing ThresholdsBody Image and the Construction of IdentityThe Body and Embodiment: The senses in relation to the Cancer journey and the role of art therapyShoreline: The reality of working in cancer and palliative careA woman with Breast Cancer in Art TherapyPerseus’ ShieldThe Efficacy of a Single SessionConnexions between creativity, individuation and the healing process: A case study with an adolescent cancer patientThe Healing Journey: A ten week group focusing on long t erm healing processesMusing With DeathGroup Art Therapy in an Oncology Department of a large general hospitalCreating through loss: How art therapists sustain their practice in palliative careArt therapy in the Hospice: rewards and frustrationsA Don’t know story: Art therapy in an NHS Medical Oncology departmentArt Therapist’s experience of Cancer

    2 in stock

    £27.54

  • Cambridge University Press A CaseBased Approach to PetCT in Oncology

    10 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    10 in stock

    £124.45

  • Cambridge University Press Childhood Leukemias

    10 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    10 in stock

    £226.10

  • Cambridge University Press Essential Clinical Immunology Cambridge Medicine Paperback

    2 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    2 in stock

    £62.69

  • Cambridge University Press Cancer of the Ovary

    1 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    1 in stock

    £61.74

  • Cambridge University Press Multiscale Modeling of Cancer

    3 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    3 in stock

    £135.85

  • Cambridge University Press Pancreatic Cancer Contemporary Issues in Cancer Imaging

    1 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    1 in stock

    £79.79

  • Cambridge University Press Prostate Cancer Contemporary Issues in Cancer Imaging

    1 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    1 in stock

    £84.54

  • Cambridge University Press Cancer Metastasis

    1 in stock

    a huge range and FREE tracked UK delivery on ALL orders.

    1 in stock

    £134.90

  • John Libbey & Co NeoAdjuvant Chemotherapy

    Out of stock

    Book Synopsis

    Out of stock

    £999.99

  • Medullary Thyroid Carcinoma

    John Libbey & Co Medullary Thyroid Carcinoma

    5 in stock

    Book SynopsisText in English & French. Proceedings of the first European Congress on Medullary Thyroid Carcinoma held in Paris (France), 15-17 November 1990. Thirty years have passed since the description by Hazard, Hawk and Crile of medullary cancer of the thyroid. Improvement in the know-ledge of the disease has concerned all its aspects, such as malignancy, endocrinology, genetics and epidemiology. This is a time of exciting dis-coveries in basic research but also of European collaboration. So, the Groupe d''Etude des Tumeurs A Calcitonine has initiated a congress de-voted to this tumour, in order to point out and transmit a statement of the question as full as possible and to open the way to a more collabo-rative approach of the disease.

    5 in stock

    £37.39

  • Cambridge University Press Interventional Oncology

    2 in stock

    Book SynopsisInterventional oncology has emerged as an important specialty within cancer care, providing targeted therapy and palliative benefits without the side effects of chemotherapy, surgery and radiation. Covering the principles of current and emerging interventional oncology techniques and detailed diagnosis, staging and treatment algorithms, this book outlines the ways in which these image-guided therapies can inform cancer management strategies. Access to the most current information is vital in this rapidly growing and evolving area of practice. This new edition reflects the most recent clinical data on interventional oncology procedures. Chapters on image guidance and targeting, tumor ablation, embolotherapy, and response assessment have been updated to reflect major technological advances, and new material on microwave ablation and irreversible electroporation has been added. This invaluable resource for interventional radiologists provides essential education and guidance on the full range of minimally invasive image-guided procedures and their integration into comprehensive cancer care.Table of ContentsPart I. Principles of Oncology: 1. Interventional oncology: the fourth pillar of cancer care Michael C. Soulen and Jean-Francois H. Geschwind; Part II. Principles of Image-Guided Therapies: 2. Principles of radiofrequency and microwave tumor ablation Anthony M. Esparaz, S. Nahum Goldberg and Muneeb Ahmed; 3. Principles of irreversible electroporation Govindarajan Srimathveeravalli and Stephen B. Solomon; 4. Principles of high intensity focused ultrasound Aradhana M. Venkatesan and Bradford J. Wood; 5. Principles of tumor embolotherapy and chemoembolization Hwan Jun Jae, Jae Hyung Park and Jin Wook Chung; 6. Principles of radioembolization Vanessa L. Gates, Riad Salem and Robert J. Lewandowski; 7. Principles of intraarterial infusional chemotherapy in the treatment of liver metastases from colorectal cancer Fidel David Huitzil Melendez and Nancy Kemeny; 8. Imaging in interventional oncology: role of image guidance Francois Cornelis and Stephen B. Solomon; 9. Novel developments in MR assessment of treatment response after locoregional therapy Kelly Fabrega-Foster, Neda Rastegar, Jean-Francois H. Geschwind and Ihab R Kamel; Part III. Organ-Specific Cancers - Primary Liver Cancers: 10. Assessment and triage of hepatocellular carcinoma Riccardo Lencioni; 11. Image guided ablation of hepatocellular carcinoma Laura Crocetti, Maria Clotilde Della Pina, Dania Cioni and Riccardo Lencioni; 12. Embolization of liver tumors: anatomy Hyo-Cheol Kim and Jin Wook Chung; 13. Conventional chemoembolization and chemoembolization with drug-eluting beads: technique and future potential Julius Chapiro, Florian Nima Fleckenstein, Lynn Jeanette Savic and Jean-François H. Geschwind; 14. 90Yttrium radioembolization for hepatocellular carcinoma Ryan M. Hickey, Riad Salem and Robert J. Lewandowski; 15. Image-guided therapy of intrahepatic cholangiocarcinoma Michael C. Soulen and William S. Rilling; Part IV. Organ-Specific Cancers - Liver Metastases: 16. Colorectal masses: ablation Elena N. Petre, Stephen B. Solomon and Constantinos T. Sofocleous; 17. Assessment, triage and chemoembolization for colorectal liver metastases Michael C. Soulen, Govindarajan Narayanan and Ursina Teitelbaum; 18. Radioembolization for colorectal liver metastases Lourens Bester, Baerbel Meteling and David Boshell; 19. Assessment, triage and liver-directed therapies for neuroendocrine tumor metastases Terence P. Gade and Michael C. Soulen; 20. Preoperative portal vein embolization David Li and David C. Madoff; Part V. Organ-Specific Cancers - Extrahepatic Biliary Cancer: 21. Extrahepatic biliary cancer: stenting, brachytherapy and photodynamic therapy Vlastimil Valek and Tomas Andrasina; Part VI. Organ-Specific Cancers - Renal Cell Carcinoma: 22. Management of small renal masses Mansi A. Saksena, Debra A. Gervais, Michael C. Soulen and Peter R. Mueller; 23. Embolotherapy in the management of renal cell carcinoma Ricardo Garcia-Monaco; Part VII. Organ-Specific Cancers - Chest: 24. Image-guided ablation in the thorax Erica S. Alexander and Damian E. Dupuy; Part VIII. Organ-Specific Cancers - Musculoskeletal: 25. Percutaneous ablation of painful metastases involving bone Matthew R. Callstrom and A. Nicholas Kurup; 26. Cementoplasty and musculoskeletal interventions Sean Tutton and Alexis Kelekis; Part IX. Organ-Specific Cancers - Prostate: 27. Prostate ablations Francois Cornelis, Jeremy C. Durack, Behfar Ehdaie, J. Coleman and Stephen B. Solomon; Part X. Specialized Interventional Techniques in Cancer Care: 28. Vascular access: venous and arterial ports Thierry de Baère and Eric Desruennes; 29. Palliative care and symptom management Drew A. Rosielle, Melissa Atwood, Sean Marks and William S. Rilling; 30. CT-guided neurolysis for cancer-related abdominal and pelvic pain Ashraf Thabet; 31. Palliative procedures for ascites and effusion Hooman Yarmohammadi.

    2 in stock

    £155.80

  • Cambridge University Press Managing Myeloproliferative Neoplasms

    10 in stock

    Book SynopsisThis is a concise, practical, case-based book documenting examples and scenarios that will help you manage challenging clinical issues for patients with myeloproliferative neoplasms. The editors and authors have strived to distil the very latest information in this rapidly advancing field in a way that will help you to update your practice and manage your patients. The key focuses are: diagnosis, both standard and challenging; both day-to-day management as well as special situations such as surgery, thrombotic events and pregnancy; and finally, managing evolving situations with MPN such as progression to acute myeloid leukemia. This book is an outstanding resource that includes a discussion of both classical myeloproliferative neoplasms, such as essential thrombocythemia, polycythemia vera and myelofibrosis, and also less common disorders such as systemic mast cell disease, hypereosinophilia, MPN/MBS overlap syndromes and atypical CML, amongst others. This book is a practical reference for practitioners, hematologists, medical oncologists and trainees.Table of ContentsPreface; 1. Initial assessment of the undiagnosed patient who has an erythrocytosis, leucocytosis or thrombocytosis Mary Frances McMullin; 2. Practical approaches to molecular testing and diagnosis of mastocytosis, hypereosinophilia and MDS/MPN overlap syndromes Nicholas C. P. Cross, Dimitra Koumaki, Georgia Metzgeroth and Andreas Reiter; 3. Incidental splenomegaly: an approach to diagnosis Craig B. Reeder; 4. When to do a bone marrow biopsy and how to interpret it in the diagnosis of myeloproliferative neoplasm Hans Michael Kvasnicka; 5. Accurately assessing risk in your myeloproliferative neoplasm patient Francisco Cervantes and Arturo Pereira; 6. Incorporating symptomatic assessment in therapy choice for patients with myeloproliferative neoplasms Robyn M. Scherber, Holly L. Geyer and Ruben A. Mesa; 7. The newly diagnosed patient with essential thrombocythemia Guido Finazzi; 8. The newly diagnosed patient with polycythemia vera Alessandro M. Vannucchi and Paola Guglielmelli; 9. Longstanding polycythemia vera and essential thrombocythemia: monitoring and management goals Loula Papageorgiou and Claire Harrison; 10. Management of myelofibrosis: which patients are candidates for JAK inhibitors and how to manage patients on JAK inhibitor treatment Lorenzo Falchi and Srdan Verstovsek; 11. Hematopoietic cell transplantation for myelofibrosis: who and when? Veena Fauble and Vikas Gupta; 12. Systemic mast cell disease, diagnosis and management Deepti Radia; 13. Hypereosinophilia: an illustrated approach to diagnosis and management Jason Gotlib; 14. Myelodysplastic/myeloproliferative neoplasm overlap syndromes Aaron T. Gerds, Ramon V. Tiu and Mikkael A. Sekeres; 15. Atypical chronic myeloid leukemia and chronic neutrophilic leukemia Daniel A. Pollyea and Jeffrey T. Schowinsky; 16. Women and children with myeloproliferative neoplasms – special considerations Robert Schneidewend and Laura C. Michaelis; 17. Conception and pregnancy in myeloproliferative neoplasms Susan Robinson; 18. Managing acute vascular events in patients with myeloproliferative neoplasms David Garcia and Bethany T. Samuelson; 19. Challenging thrombotic scenarios in the myeloproliferative neoplasms: splanchnic vein thrombosis and others Brady L. Stein; 20. Familial myeloproliferative neoplasms – implications for patients and their families Sabina Swierczek and Josef Prchal; 21. Management of acute leukemia following myeloproliferative neoplasms Raoul Tibes; Index.

    10 in stock

    £69.34

  • Cambridge University Press Fertility Preservation

    Out of stock

    Book SynopsisThis new edition provides a much-needed reference book to accommodate emerging and expanding knowledge in fertility preservation, the rapidly growing field of reproductive medicine associated with advances in oncology. Written by a team of world-leading experts in the field and comprehensive in its scope, the book covers the full range of techniques and scientific concepts in detail. It opens with an introduction to fertility preservation in both cancer and non-cancer patients, followed by fertility preservation strategies in males and females, including medical/surgical procedures, ART, cryopreservation and transplantation of ovarian tissue, and in-vitro follicle culture. Concluding chapters address new technologies, as well as ethical, legal and religious issues. The book has been thoroughly updated, includes additional contributors, and now provides greater focus on practical and clinically relevant issues. Richly illustrated throughout, this is a key resource for clinicians specialTable of ContentsSection 1 Introduction: 1. The evolution of the assisted reproduction technologies; 2. The effect of chemotherapy on the human reproductive system; 3. The effect of radiotherapy on the human reproductive system; 4. The need for fertility preservation in cancer patients; Section 2 Reproductive biology and cryobiology: 5. Life and death in the germ line: apoptosis and the origins of DNA damage in human spermatozooa; 6. Principles of vitrification as a method of cryopreservation in reproductive biology and medicine; Section 3 Fertility preservation in cancer and non-cancer patients: 7. Fertility preservation in non-cancer patients; 8. Fertility preservation in women with ovarian endometrioma: from surgery to oocyte and ovarian tissue freezing; 9. Pediatric cancer therapy and fertility; 10. Breast cancer therapy and fertility; 11. Fertility preservation in young adults with gastrointestinal and hematological malignancies; Section 4 Fertility preservation strategies in the male: 12. Transplantation of cryopreserved spermatogonia; 13. Cryopreservation and grafting of immature testicular tissue; 14. Use of cryopreserved sperm and ART after chemotherapy or radiotherapy; Section 5 Fertility preservation strategies in the female: medical/surgical: 15. Use of GnRH analogs for prevention of chemotherapy-induced gonadotoxicity; 16. Ovarian transposition before radiotherapy Yaron Gill and Togas Tulandi; 17. Fertility-saving surgery for gynaecological cancers; 18. Results of conservative management of ovarian malignant tumours; Section 6 Fertility preservation strategies in the female: ART: 19. Embryo cryopreservation as a fertility preservation strategy; 20. Vitrification of human oocytes as a fertility preservation strategy; 21. Autotransplantation of cryopreserved ovarian tissue: techniques and results; 22. ART and oocyte donation in cancer survivors; Section 7 Ovarian cryopreservation and transplantation: 23. Ovarian cryopreservation and transplantation: overview; 24. Cryopreservation of ovarian tissue by vitrification: techniques and results; 25. Ovarian tissue cryopreservation; 26. Risk of transplanting malignant cells in cryopreserved ovarian tissue; 27. Whole ovary freezing and transplantation; Section 8 In-vitro follicle culture: 28. Molecular and cellular integrity of cultured follicles; 29. In-vitro growth of human oocytes; 30. Contributions of ovarian stromal cells to follicle culture; 31. In-vitro maturation of germinal vesicle oocytes; 32. Survival of primordial follicles: tips and tricks; Section 9 New research and technologies: 33. The artificial ovary; 34. Uterus transplantation: research and clinical possibilities; 35. Ovarian allotransplantation; 36. Allotransplantation of human ovarian tissue; 37. Predicting ovarian futures: the contribution of genetics; Section 10 Ethical, legal and religious issues: 38. Fertility preservation: ethical considerations; 39. Legal issues of fertility preservation; 40. Christian ethics in fertility preservation.

    Out of stock

    £999.99

  • Cambridge University Press Understanding Cancer

    1 in stock

    Book SynopsisOne in two of us will develop cancer at some point in our lives and yet many of us don''t understand how cancers arise. How many different kinds of cancer are there? What treatments are available? What does the future hold in terms of developing new therapies? This book demystifies cancer by explaining the underlying cell and molecular biology in a clear and accessible style. It answers the questions commonly asked about cancer such as what causes cancer and how cancer develops. It explains how DNA makes proteins and how mutations can corrupt those proteins. It also gives an overview of current therapies and how treatments may advance over the next decades, as well as explaining what actions we can take to help prevent cancer developing. Understanding Cancer is an accessible and engaging introduction to cancer biology for any interested reader.Trade Review'How often have we attended a lecture or opened a book to find that within minutes we are smothered by complicated facts that are way beyond our understanding? There has been no simple introduction. The speaker/author is so involved in the topic that they could no longer see out of the intellectual hole that they had dug for themselves. If ever a book was written to dispel this fault, then this is the one, as Robin Hesketh has managed to provide a remarkably clear and readable account of the science behind cellular behaviour and faults that lead to the development of cancer. The book reads like a novel, and I found that I could hardly put it down. The literary style is at times light-hearted with humorous analogies.' Robert Whitaker, anatomist, University of Cambridge'Understanding Cancer presents a carefully crafted, clear and concise book on aspects of cancer; a disease of importance to us all. Most readers will come to Robin Hesketh's book with questions about cancer. Understanding Cancer will not disappoint. The most usual questions and answers are presented in the first chapter and ways of reducing the risk of some cancers are suggested later. This book puts cancer into a historical and very interesting context; it then explores cancer, its biochemistry and functioning in an approachable way. Information is given about the latest treatments and the science behind them. This very readable book contains something for everyone. It is positioned, and very adequately fills, the gap between personal accounts by patients of their experiences, and more advanced medical and cell biology texts. Understanding Cancer is well researched and greatly recommended.' David Archer, schools liaison officer, British Society for Cell Biology'Understanding Cancer is a fascinating and engaging perspective on the evolution of cancer research and treatment. Dr Hesketh provides insight into the key clinicians and scientists, following their discoveries in clinical care and research. He overviews the likely mutagenic causes of cancer spurring on the oncogenic transitions leading to a cancer cell that can replicate uncontrollably, highlights new avenues in cancer research, and conveys that preventive measures and advances in early cancer detection could make an impact on cancer incidence and patient outcomes/survival. This book is certainly a triumph and a must-read for all current and future scientists, physicians at any stage of their professional careers and anyone interested in cancer research and the quest for effective anti-cancer treatments.' David Lyden, David Lyden, cancer researcher and paediatric oncologist, Weill Cornell Medicine, Cornell University'… this is an enjoyable and compelling read and includes a list of references appropriate for each chapter and a helpful index … Highly recommended.' J. M. Miller, ChoiceTable of Contents1. Painting a clear picture; 2. Ancient history; 3. Counting cancer; 4. From DNA to protein; 5. What is a cell?; 6. Mutations; 7. Causes of cancer that can be controlled; 8. Causes of cancer that are difficult to control, accidents … and other things; 9. Treating cancer by chemotherapy; 10. The road to utopia?

    1 in stock

    £39.99

  • Cambridge University Press Gynaecological Oncology for the MRCOG

    5 in stock

    Book SynopsisWritten with the MRCOG examination requirements at its core, this book offers an extensive and up-to-date review of the full range of gynaecological cancers. The principles of epidemiology, imaging and treatment modalities are presented in a succinct and clinically focused manner. Each gynaecological cancer features in a stand-alone chapter, incorporating information on clinical issues, staging and principles of management. Genetic conditions and surgical principles are analysed, as well as topics such as palliative care, holistic approaches and communication. RCOG guidelines and Scientific Advisory Committee advice feature throughout the book. While authoritative and factual, the text is concise and clear. Flow-charts and diagrams support the assimilation of complex information, while practical tips, management algorithms, and clinical images enhance each chapter. Essential for those preparing for the MRCOG examination, this book is a comprehensive resource for health professionals woTable of Contents1. Epidemiology of gynaecological cancers Anjum Memon and Aisha El-Turki; 2. Pathology of gynaecological cancers Raji Ganesan and Jo Vella; 3. Imaging in gynaecological oncology Susan Freeman, Helen Addley and Penelope Moyle; 4. Concepts of treatment approaches in gynaecological oncology Mohamed Khairy; 5. Radiation therapy for gynaecological malignancies Christopher Stephen Kent and Paul Symonds; 6. Systemic therapy in gynaecological cancers Benjamin Masters and Anjana Anand; 7. Pre-invasive disease, screening and hereditary cancer Dhivya Chandrasekaran, Faiza Gaba and Ranjit Manchanda; 8. Surgical principles in gynaecologic oncology Jane Borley and Maria Kyrgiou; 9. Role of laparoscopic surgery Hans Nagar; 10. Ovarian, fallopian tube and primary peritoneal cancer (and borderline) Hilary Turnbull and Timothy Duncan; 11. Endometrial cancer Cathrine Holland; 12. Cervical and vaginal cancer Claire Louise Newton and T. A. Mould; 13. Vulval cancer Carmen Gan and Ketan Gajjar; 14. Uterine sarcomas Helen Bolton and Mahmood Shafi; 15. Non-epithelial ovarian tumours and gestational trophoblastic neoplasia Michael J. Seckl and Christina Fotopoulou; 16. Palliative care Sara Booth and Mary McGregor; 17. Living with cancer Andy Nordin and Manas Chakrabarti; 18. Communication in gynaecological oncology Nicholas Wood and Georgios Theophilou.

    5 in stock

    £55.09

© 2026 Book Curl

    • American Express
    • Apple Pay
    • Diners Club
    • Discover
    • Google Pay
    • Maestro
    • Mastercard
    • PayPal
    • Shop Pay
    • Union Pay
    • Visa

    Login

    Forgot your password?

    Don't have an account yet?
    Create account